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ABSTRACT OF THE DISSERTATION
EFFECT OF BLOOD FLOW PATTERNS ON LOCALIZED PLATELET ADHESION
UNDER PHYSIOLOGIC FLOW CONDITIONS USING TWO-DIMENSIONAL AND
THREE-DIMENSIONAL STENT MODELS - AN EXPERIMENTAL AND
COMPUTATIONAL APPROACH
by
Nandini Duraiswamy
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Miami, Florida
Professor Richard Schoephoerster, Major Professor
This dissertation presents dynamic flow experiments with fluorescently labeled
platelets to allow for spatial observation of wall attachrent in inter-strut spacings, to
investigate their relationship to flow patterns. Human blood with fluorescently labeled
platelets was circulated through an in vitro system that produced physiologic pulsatile
flow in (1) a parallel plate flow chamber that contained two-dimensional (2D) stents that
feature completely recirculating flow, partially recirculating flow, and completely
reattached flow, and (2) a three-dimensional (3D) cylindrical tube that contained stents of
various geometric designs.
Flow detachment and reattachment points exhibited very low platelet deposition.
Platelet deposition was very low in the recirculation regions in the 3D stents unlike the
2D stents. Deposition distal to a strut was always high in 2D and 3D stents. Spirally
recirculating regions were found in 3D unlike in 2D stents, where the deposition was
higher than at well-separated regions of recirculation,
vi
Platelet deposition occurred through convective transport of platelets as defined
by the instantaneous streamlines. The instantaneous streamlines were obtained from
computational fluid dynamics models of the different stents used with the same
experimental flow conditions. Platelet deposition was higher in areas where the blood
flow was directed towards the wall and lower in areas where the blood flow was directed
away from the wall.
Though the platelet deposition patterns shown in this paper were a result of a
short time-scale phenomena, convective transport plays an essential role in the interaction
of blood cells with the endothelial or exposed underlying collagen layer, which In turn
affects the development of Intimal hype lasia (IH). These results could help in improved
stent designs In future that prevent excessive platelet aggregation.
vii
TABLE OF CONTENTS
CHAPTER PAGE
1 IN TR O D U C T IO N ................................................................................................... 1
1.1 Cardiovascular System of the Human Body 1................................................1
1.2 Structure and Function of Vasculature ............................................................. 2
1.3 Composition of Blood and Their Functions ...................................................... 4
1.3.1 Vascular Injury ............................................................................................ 5
1.4 Atherosclerosis ................................................................................................ 6
1.5 Stents ............................................................................................................. 10
1.5.1 Vascular Response to Stenting . . . .. . ........... 11
1.5.2 Thrombosis - Role of Platelets in Restenosis ............................................ 11
1.5.3 Role of Endothelial Cells in Restenosis ....... .............................................. 13
1.5.4 Stents and Restenosis - A Strong Link ........................... .......... 14
1.5.5 Restenosis - Influence of Flow Patterns and Arterial Wall Stress .......... 18
1.5.6 Flow effects on Platelet Deposition ............................................................ 24
1.6 Problem Statement - Study Objectives ...................................................... 25
2 EXPERIMENTAL AND COMPUTATIONAL METHODS..................................28
2.1 In vitro Experient...28
2.2 Computational Fluid Dynamic (CFD) Simulation .. 39
2.2.1 Parametric Comparison of 3D Generic Stented Models .............................. 40
2.2.2 Blood Flow Patterns of 2D and 3D Stents used Experimentally .................. 49
3 R E SU L T S ............................................................................................................. 54
3.1 Platelet Deposition and Computational Results of 2D Stented Models ........... 54
3.2 Computational Results of 3D Generic Stented Models ................................... 60
3.3 Platelet Deposition and Computational Results of 3D Stented Models ........... 77
4 DISCUSSION ..................................................................................................... 105
4.1 2D Experimental Stented Models ................................................................. 1 6
4.2 Generic 3D Parametric Stented Models.......... ............... . .................... 113
4.3 3D Experimental Steted Models .................................................................. 121
4.4 General Discussion on Platelet Deposition and Its Relationship to
Flow Dynamics..........................................................................................132
4.5 Conclusion and Future work ........................................................................ 138
R EFER E N C E S .......................................................................................................... 44
APPENDIX.................................................................................................................155
V IT A .......................................... 1........................................................... ........... 72
viii
LIST OF FIGURES
FIGURE PAGE
1. Schematic diagram of the three layers (intima, media, and adventitia) of an artery ....... 3
2. Schematic diagram depicting an acute plaque rupture and resultant thrombus
formation with major physiological pathways involved in the process ..................... 6
3. (a) Fully recirculating region, (b) Partially recir culating at higher flow rates
and partially reattaching at lower flow rates, d (c) Fully reattached region .......... 21
4. Schematic (exploded view) of the in vitro test system ............................................... 28
5. Schematic of the 2D stainless steel stent ............................................................. .. 29
6. Schematic of the 3D stented cylindrical flow chamber ............................................... 30
7. Sche atic of 4 different 3D stent types that were tested for platelet deposition 31
8. Schematic diagram of in vitro flow system .................................................... 33
9. Sample image taken between struts of intermediate strut spacing at 3 different time
points: (a) time zone 1, (b) time zone 2, and (c) time zone 3 .................................. 35
10. Sample image taken between struts of Wall stent at 3 different time points:
(a) time zone 1, (b) time zone 2, and (c) time zone 3 ............................... ............ 37
11. (a) computational domain and (b) computational mesh of one of the stent models
used in plane (see x ) ........................................................... . 41
12. Four parametric models of stent struts geometries. (a) h=1.8mm, f=0.9mm,
r=0.45mm, (b) h=1.8mm, f=1.8mm, r=0.9 (c) h=3.6mm, 1-.8mm,
r=0.9mm, and (d) h=3.6mm, f=3.6mm, r=0.9mm................................................... 43
13. (a) The velocity profile curve (also shows time point tl (30t time point)) and the
cor esponding WSS for low flow condition and (b) The velocity profile curve
(also shows time point tl (30" time point)) and the corresponding WSS
for high flow condition. .............................................................................. .... 48
14. (a) Line-probe locations at 0.25H, 0.5H, 2H, ... , 10H shown for stent model
(b) with connector; used for obtaining WSS information along the length of the
line-probe at each location. Streamlines at 30t ti estp for h=1.m, -1.8m
r=0.9mm model with connector for (b) low flow and (c) high flow ................... 49
15. (a) Computational structured grid domain of stent type (b) ...................................... 51
ix
16. Mesh convergence for (a) Bx Velocity stent and (b) Wall stent...............................52
17. Simulation showing that an entrance length of 8mm was sufficient for
experimental purposes...........................................................................................53
18. (a) Average normalized platelet deposition at the inlet to first strut plotted as a
function of distacc (in ). (b) Path of instantaneous streamlines at minimum
flow (Q represents the flow rate) at the inlet to first strut ........................................ 55
19. (a) Average normalized platelet deposition between struts of that smallest strut
spacing plotted as a function of distance (in mm). (b) Path of the instantaneous
streamlines at minimum flow (Q represents the flow rate) between the struts of
sm allest spacing.............................................................................................. . 56
20. (a) Average normalized platelet deposition between struts of largest spacing
plotted as a function of distance (in mm). (b) Path of instantaneous streamlines at
minimum flow (Q represents the flow rate) between struts of largest spacing ......... 58
21. (a) Average normalized platelet deposition between struts of intermediate spacing
plotted as a function of distance (in mm). (b) Path of instantaneous streamlines at
minimum flow (Q represents the flow rate) between struts of intermediate
spacing. c) Path of instantaneous streamlines at peak flow between struts of
intermediate spacing .............................................................................................. 59
22. (a) Average normalized platelet deposition at the outlet to last strut plotted as a
function of distance (in mm). (b) Path of instantaneous streamlines at minimum
flow (Q represents the flow rate) at the outlet to the last strut ................................. 61
23.Contour plot of (a) mean axial WSS, (b) mean transverse WSS, and (c) separation
parameter, for the h=l.8mm, f-09mm, r-0.45mm model (stent model (a)) with
connector under hig fow .................................................................................. 64
24.Contour plot of (a) mean axial WSS, (b) mean transverse WSS, and (c) separation
paramneter, for the h=1.8mm, f=0.9mm, r=0.45mm model (stent model (a))
without connector under high flow........................................................................ 65
25. Contour plot of (a) mean axial WSS, (b) mean transverse WSS, and (c) separation
parameter, for the h=1.8m f09m , 0.45mm model (stent model (a)) with
connector under low flow ..................................................................................... 66
26. Contour plot of(a) mean axial WSS, (b) mean transverse WSS, and (c) separation
parameter, for the h=1.8 -=1.8 -0.9mm model (stent model (b)) with
connector under low flow. .................................................................................... 67
27. Contour plot of (a) mean axial WSS, (b) mean transverse WSS, and (c) separation
parameter, for the h=3.6mm, f=1.8mm, r=0.9mm model (stent model (c)) with
connector under high o ..............................................................................., 70
x
28. Contour plot of (a) mean axial WSS, (b) mean transverse WSS, and (c) separation
parameter, for the h=3.6mm, f-3.6m, r=0.9m model (stent model (d)) with
connector under high flow .................................................................................... 71
29. Normalized mean axial WSS between struts in different strut geometries for high
and low flow conditions. First two geometries correspond to h=1.8mm models,
third and fourth geometries correspond to h=3.6mm models ....... .......... 72
30. Mean transverse WSS between struts in different strut geometries for high and
low flow conditions ............................................................................................. 73
31. Percentage area between struts where the separation parameter >0.5 in different
strut geometries for high and low flow conditions..... ............................................. 74
32. Percentage area between struts where the separation parameter ranged from
0.1-0.5 in different strut geometries for high and low flow conditions .................... 76
33. Axial wall shear stress variation and separation parameter variation within the
stented geometry of Bx Velocity stent .................................................................... 78
34. Axial wall shear stress variation and separation parameter variation within the
stented geometry of NIR stent................................................................................79
35. (a) Platelet deposition at the inlet just before first strut for Wall stent ..................... 82
36. (a) Platelet deposition taken between struts for Wall stent; two geometries within
the sam e stent type is shown.............................................................................84
37. (a) Platelet deposition at the outlet just after the last strut for Wall stent.................. 86
38. (a) Platelet deposition at the inlet just before first strut for Bx Velocity stent...........88
39. (a) Platelet deposition between struts for Bx Velocity stent............................ ... 91
40. (a) Platelet deposition at the connector for Bx Velocity stent ................................... 93
41. (a) Normalized average platelet intensity at the outlet to concave end of the last
strut for Bx Velocity stent; (b) normalized average platelet intensity at the outlet
to convex end of the last strut ................................................................................ 96
42. (a) Normalized average platelet deposition in the region between struts for
A urora ste9t................................................................................................. . 97
43. (a) Platelet deposition at the connector for Aurora stent........................................... 98
44. (a) Platelet deposition at the no-connector region for Aurora stent ........................... 99
Xi
45. (a) Normalized average platelet deposition at the inlet just before the first strut
for NI stent ........................................................................................................ 1
46. (a) Normalized average platelet deposition between the first two struts for NIR
ste t1.....................................................................................................................102
47. (a) Platelet deposition at the connector region for NIR stent..... ....... 104
48. Figure summarizes average platelet deposition based on the flow regime under
consideration and the direction of flow of streamlines................................ 108
49. Mean wall shear stress distribution between struts of largest strut spacing ............. 135
50. (a) Streamlines (at maximur flow rate) above the proximal portion of the
connector have the capability to travel distal to the connector for NIR stent......... 141
xi
1 INTROUCTION
This section reviews the background information on the some of the main topics
involved as part of this research - cardiovascular system, structure and functioning of
arteries and blood cells, process of thrombosis and role of blood platelets in thrombosis,
formation of atherosclerosis, conventional treatment methods, use of metallic scaffolds
called stents with conventional treatment, advancements in stent design, how stent design
influences mechanical factors that in turn influence restenosis rates, brief review of all the
mechanical factors involved, and the primary goal behind this research.
1.1 Cardiovascular System of the Human Body
The cardiovascular system is comprised of the heart; a four chambered in-series
pump, and the connecting vasculature: the arteries, veins, microvasculature, and
lymphatic vessels. The primary function of the cardiovascular system is to deliver
oxygen, nutrients, and chemical messengers to the respiring cells. In turn, the
cardiovascular system removes cellular waste and delivers it to the appropriate organ for
elimination or degradation. The cardiovascular system also assists in maintaining normal
fluid balance and plays a key role in thermoregulation (Robinson S et al., 1965). Function
of the cardiovascular system is regulated by several factors:
(a) inherent properties of cardiac muscle i.e. the pacemaker potential, gap junctions
(Ishii K and Honda 1965),
(b) inherent properties of vascular smooth muscles, i.e. contraction, relaxation,
stretch (Karoon P et al., 1998)
(c) neural control i.e. baroreceptor reflex (Hull D and Seagull MM, 1965),
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(d) autonomic nervous system, and endocrine control, i.e. circulating
catecholamines, insulin, thyroid hormone etc (Draskoczy PR and Lyman CP, 1967).
Homeostatic control of cardiovascular function consists of both long-loop reflexes and
local control mechanisms. This angement allows for integrated regulation of arterial
pressure, cardiac output and fluid balance while simultaneously adjusting perfusion
(blood flow) in local circulatory beds. Interestingly the system contains endocrine-like
cells that assist in its regulation by secretion of chemical messengers such as atrial
natriuretic hormone, nitric oxide (NO), and prostacyclin (Resnik R, 1981; Staszewska-
Barczak J, 1978).
1.2 Structure and Function of Vasculature
Arteries, arterioles, and capillaries form the network of vessels through which
oxygenated blood is transported from the heart to the body. Consequently, any damage
or disease afflicting these vessels can lead to diminished supply of nutrients to the tissue.
Therefore the understanding of the structure and diseased states is critical before
considering treatment Arteries are composed of three distinct layers namely the intima,
media, and adventitia with connective tissue sandwiched between each layer (Moore DH
and Ruska H, 1957; see Fig. 1). Each layer serves in providing strong d elastic
mechanical properties that ensures that high pressures can be withstood in the arteries.
Arteries and veins have the same three tissue layers, but the proportions of these layers
differ. The innermost is the intima; next comes the media; and the outermost is the
adventitia. Arteries have thick media, made of smooth muscle cells (SMC) surrounded by
connective tissue composed of collagen fibrils, elastic fibers, and structural
glycoproteins, to absorb the pressure waves created by the heart's pumping. The smooth-
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muscle media walls expand when pressure surges, then snap back to push the blood
forward when the heart rests. The smooth muscles in the media can provide
vasoconstriction and vasodialation in order to influence pressure and blood flow
(Kochemasova NG, 1967).
EXTERNAL ELASTIC MEMBRANE VESSELS OF ADVENTITIA
INTERNAL ELASTIC -TUNICA ADVENTIIA
MEMBRANE
ARTERY
CIRCULAR MUSCLES
VALV E
TU NICA INTIMA
TUNICA INTIMA .Is -
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CIRCULAR MUSCLES wVI
FAT CELLS ,
Figure 1. Schematic diagram of the three layers (intima, media, and adventitia) of an
artery and a vein.
As blood enters the capillaries, the pressure falls off. By the time blood reaches
the veins, there is little pressure. Thus, a thick media is no longer needed. Surrounding
muscles act to squeeze the blood along veins. Valves in veins are used to ensure flow in
the right direction. The adventitia is composed primarily of connective tissue with
interspersed elastic and collagen fibers (Ragan C, 1952). The intima is composed of a
single layer of endothelial cells (EC). The EC layer forms a continuous, selectively
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permeable, and thrombo-resistant barrier (Gherdol A and Vales 0, 1966). Since blood
flows adjacent to the EC, they are responsible for the prevention of t ombosis and
homeostasis on the inner surface of the artery. Regulation ofthrombus formation by EC
takes place through the secretion of certain biochemicals (Higgs GA, 1977).
1.3 Composition of Blood and Ther Functions
The components of the blood not only serve as a vehicle to transfer oxygen and
nutrients, but also as serve in maintaining a normal functioning vasculature. Adults have
up to 7-8 liters of blood in the body. Forty-five percent (45%) consists of cells - platelets,
red blood cells (RBC), and white blood cells (WBC - neutrophils, basophils, eosinophils,
lymphocytes, monocytes) (Larcan A, 1965). Fifty-five percent (55%) consists of plasma,
the liquid component of blood. Plasma is a straw-colored, clear liquid that is 90 percent
water, and it is an essential ingredient for human survival. Besides water, plasma also
contains dissolved salts and minerals like calcium, sodium, magnesium, potassium, and
many mcrobe-fighting antibodies.
Red blood cells (RBC) perform the most important function of providing nutrients
to all the cells. They are devoid of nucleus and have the shape of a biconcave disc with a
diameter of 8 microns. There are about 4-6 million RBCs per microliter of blood. Red
blood cells are red only because they contain a protein chemical called hemoglobin which
is bright red in color. Hemoglobin contains the element Iron, making it an excellent
vehicle for transporting oxygen and carbon dioxide (Stich W, 1964). As blood passes
through the lungs, oxygen molecules attach to the hemoglobin. As the blood passes
through the body's tissue, the hemoglobin releases the oxygen to the cells. The empty
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hemoglobin molecules then bond with the tissue's carbon dioxide or other waste gases,
transporting it away.
The white blood cells (WBC) are the protectors of the body against infection.
They are less numerous than the RBCs, about 5000-7000 per microliter of blood. But
they are the largest of cells in the blood, about 10-12 microns in diameter.
Platelets are responsible for maintaining hematostasis and thrombosis through the
initiation of blood coagulation as well as the proliferation of vascular cells (Maupin B,
1955). Platelets are round discs of 2-3 microns in diameter and range in concentration
between 200,000 to 300,000 platelets per microliter of blood in most healthy people.
1.3.1 Vascular Injury
The interaction of the vasculature and platelets can be seen in the formation of
thrombus and in hemostasis during vascular injury (Maupin B, 1955). This process is
important to prevent the loss of body fluids. If the endothelial layer of the vessel wall is
denuded, the subendothelial layer of collagen is exposed to the blood in the lumen (see
Fig. 2). The initial phase of the hemostatic process is vascular constriction. This limits the
flow of blood to the area of injury. Next, platelets become activated by thrombin and
aggregate at the site of injury, forming a temporary, loose platelet plug (Vassar PS and
Spain DM, 1953). The protein fibrinogen is primarily responsible for platelet-to-platelet
binding, resulting in clumping. Platelets clump by binding to collagen that becomes
exposed following rupture of the endothelial lining of vessels (Winer GD e aL., 1968).
Upon activation, platelets release adenosine-5'-diphosphate (ADP) and t omboxine
(TXA2) (which activate additional platelets), serotonin, phospholipids, lipoproteins, and
other proteins important for the coagulation cascade. Thrombus is generated through the
5
activation of enzymes in the coagulation cascade (Macfarlane RG, 1964). In addition to
induced secretion, activated platelets change their shape to accommodate the formation of
the plug. To ensure stability of the initially loose platelet plug, a fibrin mesh (also called
the clot) forms and entraps the plug. Finally, the clot must be dissolved in order for
normal blood flow to resume following tissue repair. The dissolution of the clot occurs
through the action of plasmin (Alkjaersig N et al., 1959).
Macrophage Number Ox LDM'1
and Cholestcrol Ox-LDL [ t
Ester Accumulation 4ILp..
Lipid Core
Figure 2. Schematic diagram depicting an acute plaque rupture and resultant thrombus
formation with major physiological pathways involved in the process. Presence of
recirculation regions may increase the degree of plaque formation in that region.
1.4 Atherosclerosis
Arteriosclerosis, a general word for thickening of the arterial wall, remains the
most common disease of the cardiovascular system in developed countries.
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Atherosclerosis is characterized as the buildup of plaque containing cholesterol and
lipids, which reduces the lumen of the artery (Becker GH et al., 1949). Atherosclerosis is
a type of arteriosclerosis. It comes from the Greek words Athero meaning gruel or paste
and Sclerosis meaning thickening. It forms mainly in large or medium-sized arteries like
the carotids, abdominal aorta, and femoral arteries. Though the actual cause of formation
of this plaque in certain arterial locations or in certain people is still unknown, many
scientists still believe that atherosclerosis starts because the innermost layer of the artery,
the endothelium is damaged (Bjorkerud S and Bondjers G, 1971). The damaged
endothelium plays an important role by expressing adhesion molecules that bind and
facilitate the transportation of circulating monocytes into the subendothelial layer. These
monocytes then becomne phagocytic macrophages in the intima that engulfs excess
cholesterol in the blood (Yut i C et al., 1999). Continual bathing of these cells by
plasma lipoproteins provides cholesterol for uptake by macrophages (Yutani C et al,
1999). Cholesterol is stored within the macrophage foam cell, which secretes both growth
and chemotactic factors. This results in accumulation of additional macrophages, other
leukocytes from the blood, and smooth muscle cells. As more cholesterol is deposited,
fibrosis and cell death occurs. As the mass grows, flow is compromised in the arterial
lumen. The risk of plaque rupture is dependent on plaque composition and not on plaque
size (Falk E, 1992). Inflammatory processes takes over as further thrombosis is triggered
when plaque breaks and exposes collagen and extracellular lipids to the blood, which
may lead to additional accumulation of platelets and fibrin. Apart from the response-
to-injury theory, there are other theories like "excess low-density lipoprotein overwhelm
healthy endothelium", "lack of nitric oxide production enhance platelet activation", and
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"hemodynamic factors of the arterial flow system determine site of atherosclerosis"
(Faergeman 0, 1979; Glagov S et aL., 1961).
For such atherosclerotic patients, the most non-surgical technique known to open
up obstructed arteries is percut eous tr sluminal angioplasty (PTA) (Lorimer WS Jr,
1961). 'Percutaneous' means opening is made from the exterior, ie., the skin,
'transluminal' means procedure performed within the blood vessel, and 'angioplasty'
means to reshape the blood vessel. PTA uses a balloon to increase the arterial lumen in
areas where arteriosclerotic lesions have compromised blood flow (Athanasoulis CA,
1980). The plaque is broken at the point of least resistance and/or redistributed within the
intima reestablishing and improving the lumen diameter.
The success in performing PTA is to open up the clogged arterial lumen for free
flow of blood. The most common serious complication of PTA is acute occlusion of the
dilated vessel due to dissection or thrombosis. This may require 'bail-out' stenting or
even emergency coronary artery bypass grafting (~2%) and can lead to death (~1%) or
non-fatal myocardial infarction (3-4%) (Ellis SJ et al., 1997). Other complications
include vascular damage, t omboembolism including stroke, and haemorrhage due to
anticoagulant therapy. Nevertheless, the overall procedural mortality is ~1% (Ellis SJ et
al., 1997).
The success and complication rate of angioplasty is influenced by many factors
including age, sex, clinical presentation, left ventricular function, co-morbidity (e.g.
diabetes mellitus), and the experience of the operator (Melke R et al., 1994). However,
the single most important determinant of outcome is the nature of the target lesion. A
short, discrete, soft lesion on a straight segment of artery, which does not compromise a
major branch, is ideal for PTA (Capek P, 1991). In other words, PTA has a high success
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and low complication rate for ideal lesions but a low success and high complication rate
for complex lesions.
Most of improvement in luminal diameter following balloon angioplasty results
from stretching of the vessel wall by the balloon (Kinney TB et cal., 1984). Balloon
inflation actually results in overstretching of the vessel wall and partial disruption of not
only the intimal plaque but also the media and adventitia, resulting in enlargement of the
lumen and the outer diameter of the vessel. Axial redistribution of plaque material also
contributes to improvements in lumen diameter (Kinney TB et al, 1984). This may be
the reason for vessel recoil after balloon angioplasty and that is how the intravascular
stents camne to be used more often (since 1990s). Plaque compression is now understood
to account for very little of the observed improvement following balloon angioplasty
(Kinney TB et aL, 1984).
Restenosis is yet another complication introduced post-angioplasty procedures
reducing the success rate. Restenosis is reclogging of the arterial lumen as a result of
thrombosis and arterial wall remodeling due to smooth muscle cell hyperplasia.
Restenosis occurs predominantly within the first 3-6 months, the restenosis rates for
successful balloon angioplasty procedures range from 44% to 77% (Escaned C et cal,
1999). Restenosis occurs as a direct result of the procedure itself, where there is damage
to the arterial wall in the form of endothelial denudation; once the thromboresistant
vascular layer is removed, the deeper layers of the artery get exposed to the flow of
blood. The endothelial denudation disrupts the regulatory mechanisms of the arterial
wall, This results in remodeling through thrombosis and smooth muscle cell migration
and proliferation forming intimal hype lasia and then obstruction of the lumen, thus
restenosis (Edehnan ER and Rogers C, 1998; Nugent eta!., 1999; Rogers C et a., 1999).
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Restenosis does not always lead to recurrent symptos and can potentially be reduced by
deploying intravascular stents (Altmann DB et aL, 1996; Knight CJ et aL, 1997; Serruys
PW et aL, 1994; Serruys PW et aL, 1996; Versaci F et aL, 1997).
1.5 Stents
Stents are metallic scaffolds that when placed in an artery after the angioplasty
procedure establish the lumen diameter ad prevent vessel recoil (Yutani C et aL, 1999).
Stent implantation is very common and is included in 70-90% of angioplasty procedures.
The first stent came to be used by Charles Dotter in 1969. They are usually made of two
different material alloys - stainless steel and nitinol (Sigwart U, 1990); other materials
like tantalum and biodegradable plastic are also under clinical investigation. Stents fall
into two broad range of delivery mechanisms: balloon expandable and self-expanding.
Balloon expandable stents are mounted on angioplasty balloons catheter and deployed by
inflating the balloon. Self-expanding stents constrained onto a catheter and covered by a
sheath. Deployment is accomplished through the withdrawal of the sheath. The stiffness
of stainless steel stents is high, whereas nitinol stents are able to change their geometry
with change in the vessel geometry as a result of curvature, and/or pulsatile flow (Yachia
D and Aridogan IA, 1996). The restenosis rate that develops with intravascular stents
after angioplasty are far lower than that with angioplasty alone. (Fischman DL et aL,
1994; Pepine CJ et aL, 1996). Stents compared to PTA resulted in lower rate of
angiographically detected restenosis, improved procedural success rate, improved event-
free survival, and less frequent need for revascularization of the original artery (Fischman
DL et aL, 1994; Pepine CJ et aL, 1996). However the presence of acute and subacute
10
thrombotic occlusions remains a significant problem with 20%-40% of patients receiving
stents (Yutani C et al., 1999).
1.5.1 Vascular Response to Stenting
The cause of restenotic occlusion of stented arteries has been mainly neointimal
hyperplasia (Edelman ER et al., 1998). There are four phases of vascular response to
stenting: (1) thrombosis - remains a feature of every stent; acute thrombosis after stent
placement have been treated with anti-thrombotic drug therapy, but has less effect over
long-term restenosis; the extent of thrombosis over each stent strut depends on how deep
the strut is inside the vessel wall; (2) inflammation - the thrombus that forms at the struts
as well as on the vessel wall between struts becomes the site of inflammato reaction in
which monocytes and leukocytes adhere to the internal elastic laminae; the number of
adhered leukocytes determine the rate of proliferation within the stented region; after
approximately a week, the tissue becomes infiltrated with macrophages; these cells
migrate from the luminal surface to the developing neointima to form multinucleated
giant cells around stent struts; (3) proliferation - smooth muscle cells and macrophages
within the neointima proliferate after a week of stenting; (4) remodeling - increased
strain on the arterial wall due to the stent struts causes collagen deposition and fibrosis
near the adventitia, with persistent inflammatory processes, to cause arterial sh age
(Edelman ER et al., 1998).
1.5.2 Thrombosis - Role of Platelets in Restenosis
Thrombosis was determined to play a leading role in neointimal hyperplasia after
stenting. It was hoped that interfering with the thrombotic processes would eliminate the
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remaining three phases of vascular response to stentmg (Rogers C et a!., 1993). But
studies have shown that restenosis can continue even without thrombus formation (De
Scheerder I et al., 1997; Rogers C et a!., 1993, 1997). The coagulation process is a
cascade of events and the use of the anti-thrombotic medication may have completely
bypassed the cascade in the coagulation pathway that could have been involved with
restenosis. After vascular injury, the exposed subendothelial collagen leads to rapid
adhesion of platelets, through von Willebrand factor binding to the glycoprotein Ib-IX-V
complex (Legrand YJ et al., 1983). After adhesion, the platelets get activated, undergo
conformational changes, and release various mediators that stimulate the formation of the
platelet plug and thus platelet aggregation. These activated platelets help in the formation
of the thrombus at the injury site. Studies of neointimal formation in both porcine and
rabbit models show that mural thrombus at the injury site is a major determinant of
neointimal hyperplasia formation (Miller DD et al., 1996; Wilensky RL et al., 1995).
Several chemotactic agents released by platelets such as platelet-derived growth factor,
serotonin, histamine, and thromboxine A2 have stimulatory effect on smooth muscle cell
migration and proliferation (Sdringola S et al., 2000). The smooth muscle cells are
known to migrate to the intima from the media and change their phenotype. The presence
of thrombin and fibrin attracts inflammatory cells like the monocytes or
leukoc es/neutrophils to the vessel wall (Welt FGP et al., 2000; Yut i C et al., 1999).
Leukocyte adhesion may be the greatest predictor of cellular proliferation rate at the site
of injury (Welt FGP et al., 2000). The platelets are responsible for interaction with these
cells by release of certain adhesion molecules and chemotactic agents. Later on,
macrophages infiltrate through the vessel and concentrate mainly around the stent struts
forming giant cells (Komatsu R et aL, 1998). These cells probably act as stimulants to
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smooth muscle cell proliferation. The early neointima consists of macrophages and
spindle shaped smooth muscle cells. After the proliferative phase, these spindle shaped
cells change their phenotype to the active state, to form the final neointimal layer around
stent struts. In short, many cells in the blood stream interact very closely with the cells of
the injured stented arterial wall in the formation of neointima. Though most of the studies
carried out on animal models cannot be directly applied to humans, there is considerable
evidence that platelets are the foremost cells to be activated after vascular injury and play
a key role in neointimal formation and thus restenosis.
L5.3 Role of Endothellal Cells in Restenosis
Endothelial cells are a monolayer of cells that line the intimal layer of the artery.
They are responsible for the anti-thrombotic response of the arterial wall. During PTA,
the endothelium is denuded and the underlying collagenous layer is exposed to blood.
The eventual restoration of endothelial integrity via ingrowth from neighboring normal
vessel segments brings an end to the hyperplastic process (Clowes AW et al., 1983;
Fishman JA et aL, 1975). Histological staining revealed endothelial cell loss within
minutes of stent expansion in arteries without PTA; however in contrast there was some
residual endothelium intact after PTA in most cases (Fishman JA et aL, 1875; van
Beusekom HM et al., 1998). Stent placement after endothelial denudation resulted in
two-fold more neointimal hyperplasia than does stent placement without preceding
denudation (Rogers C et al., 1996). The endothelial injury was most severe in stent
interstices and was least severe adjacent to struts (Rogers C et al., 1996). Factors that
contribute to this type of arterial injury may include balloon-wall contact, excess pressure
on the wall imposed by blood during stent expansion, eccentric strain on the wall after
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stent implantation, or acute alterations in flow (Rogers C et al., 1996). Shear stress has
been known to be a mechanical force for modulation of cellular function (Davies PF,
1995; Traub 0 and Berk BC, 1998). Cellular function could be changed by the release of
vasoactive substances, change of gene expression, cell metabolism, and cell morphology.
Re-endothelialization of injured artery walls occurs through the migration and
proliferation of endothelial cells of the intact surrounding endothelium. Endothelial cell
migration rate increased when exposed to high shear stress flow relative to that observed
under static no flow or low shear conditions (Sprague EA et al., 2000). The flow
restricted stents also had a greater mixture of myofibroblastic and thrombotic material
covering the entire region between and on stent struts (Goetz R et aL, 1999). Histologic
evidence showed that the neointimal thickness of flow restricted stents were significantly
higher than that of flow nonrestricted stents (Goetz R et aL., 1999). Thus, endothelial cells
play a key role in preventing neointimal hyperplasia and thus, maintain vascular
homeostasis.
1.5.4 Stents and Restenosis - A Strong Link
Factors such as poor flow, pre-existing intraluminal thrombus, small native vessel
size, increased platelet counts, multiple overlapping stents, stent/vessel diameter
mismatch and the length of stent used have been suggested as possible sources leading to
intimal hyperplasia and the failure of the device (Yut i C et al., 1999). New procedures
and stents have been introduced to inhibit neointimal hyperplasia and reduce restenosis
rates.
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Brach herapy (radiation therapy) after stentng has proved ieffective due to a
greater rate of late total occlusion related to stent thrombosis rather than the occlusive
intimal hyperplasia seen with stenting only (Salame MY and Douglas JS Jr., 2001).
Drug-coated Stents
Recently it has been demonstrated that coating stents with antiproliferative drugs
is effective in coronary arteries, with reductions in restenosis rates and adverse cardiac
events (Lau KW et al., 2004; Morice MC et al., 2002). New stents with drug eluting
properties have sought to control intimal hyperplasia and facilitate recovery by
administering pharmacologic agents to the surface of the vessel. These drugs (like
sirolimus, paclitaxol) target and inhibit smooth muscle cell proliferation.
The restenosis rates for drug-coated stent implanted patients were reduced to
single digits, thus quantifying their short-term success (over six months) (SIRIUS or
RAVEL study, Morice MC et al., 2002). However, long-term efficacy of such stents is
not completely known. Recently, long-term risk of clots has been reported in certain
patients with drug-coated stents (Wall street journal, reported October 21 , 2005). In
peripheral applications such as femoral and popliteal arteries, the angiographic,
hemodynamics, and clinical success of stent placements after one and two years is lower
compared to PTA (Cejna M et al., 2001; Grenacher L et al., 2004). In drug-coated stents,
anti-proliferative coatings appear to slow the healing response (Virmani R et al., 2003).
The long-term failure mode in these arteries may be inadequate healing, marked by
thrombus formation and delayed int al regrowth (Virmani R et al., 2003). Thus, the use
of inhibitory drugs in the periphery may not be effective over a long-term period.
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Endothelial Cell Antibody-coated Stents
The endothelial cells can be affected by the interaction with the surface of the
device as well as with the size and shape of the device it must cover (Simon C et al.,
2000). The cell-covered area and migration distance significantly decreased on objects 75
microns thick, and it was nonexistent on objects 250 microns thick. Areas devoid of cells
or gaps were largest adjacent to the downfiow side of the object, disposed transversely to
flow. That is how the possibility for using progenitor endothelial cells for risk
stratification was explored (Shirota T et aL, 2003). These progenitor endothelial cells
circulate in the blood and carry endothelial-specific adhesive markers and also have some
similar cellular functions as that of normal endothelial cells. Stents are being tried with
coatings of antibodies that attract progenitor endothelial cells that help in endothelial
layer repair from angioplasty and stent implantation (Aoki J et aL, 2005). Short-term and
long-term efficacy is still under trial using EC antibody-coated stent.
What we learn? - Regardless of stent design or coating technology, the initial
thrombotic reaction certainly effects the subsequent reestablishment of the endothelium.
Thus, a better understanding of the dynamics of platelet adhesion to stents under realistic
flow conditions can serve to improve stents of all types in coronary and peripheral
applications.
Stent Design Influences Restenosis
One of the strongest factors for incidence of restenosis is the stent design, second
only to vessel size (Kastrati AJ et al., 2001). Many clinical studies have shown that
failure rates are highly dependent on stent design (Kastrati AJ et al, 2001); restenosis
ranged from 20% to 50% depending on the stent type implanted. Changing stent
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configuration to reduce strut-strut intersections by 29% while holding diameter, mass,
and surface area constant in denuded rabbit iliac arteries reduced vascular injury by 42%,
by reducing the radial force exerted on the vessel due to the stent (Rogers C et al., 1995).
Surface area coating of the stent with an inert polymer (exact kind unknown from
publication) resulted in reduced thrombosis by 69% in the corrugated design compared to
the slotted tube design (Rogers C et al., 1995). It was thus demonstrated that stent
thrombosis can be limited both by using innovative configuration design to reduce the
amount of deep injury to the vessel and by applying a coating at the interface of the metal
stent with the blood vessel wall (Rogers C et al, 1995). The polymer coating might
attenuate stent thrombosis by reducing the electronegativity and resultant corrosion of the
metal, in turn limiting the hemodynamic and chemical stimuli for platelet adhesion and
aggregation and enhancing endothelial cell recovery, among other effects (Lahann J et al.,
1999). But these coatings do not reduce the vascular injury caused to the vessel wall.
Neointimal hyperplasia in a way is a direct effect of the vascular injury caused. Reducing
strut-strut intersections by 29% reduced neointimal hyperplasia by 38% (Rogers C et al:
1995). It is possible that stents of different configurations or designs might differ in the
extent to which they denude intact endothelium during deployment, and remnant
endothelium within the stented artery might enhance regrowth d limit or vary both
thrombosis and neointimal hype lasia. Alterations in secondary flow patterns and flow-
induced wall shear stress can modulate intial hyperplasia via their effects on platelet
and inflammatory cell transport toward the wall, as well as direct effects on the
endothelium (Eigenthaler M et al., 2003; Weyrich AS et aL., 2002). Therefore,
differences in hemodynamic conditions produced by different stent designs may affect
clinical outcomes of stenting.
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.5.5 Restenosis - Influence of Flow Patterns and Arterial Wail Stress
Many mechanical factors like compliance mismatch, solid mechanical wall
stresses, fluid mechanical wall shear stresses, and fluid dynamics play an important role
in in-stent restenosis. Some issues are discussed as below.
Role of Other Mechanical Factors - Compliance Mismatch
Stresses may be induced on the arterial wall based on the stent-to-artery diameter
expansion ratio (LaDisa JF Jr. et al., 2004). The radial force exerted on the wall by the
stent creates large non-physiologic stresses in addition to altering the behavior of the
artery from an elastic tendency to a nearly rigid tendency. The abrupt changes to the
mechanical properties at the ends of the stent create zones of high stress gradients
(Mohammed Z et al., 2000). In order to get back to the physiological levels of stresses,
the artery has to increase its thickness; this is possible through smooth muscle cell
proliferation and thus neointimal formation. The compliance mismatch caused by a stent
is very similar to the mismatch that occurs in graft-artery anastomosis (Ballyk PD et al.,
1998). Anastomosis is a term used to describe the interface between the artery and a graft
or a vein that is used as a bypass. The stresses are much lower in an end-to-end
anastomosis compared to an end-to-side anastomosis. A compliance matching stent
(CMS) has been developed to reduce the stress concentration gradients and provide a
gradual change in compliance between the non-stented artery and the stented segment; it
has been shown that such a CMS reduces the local flow disturbances (Berry JL et al.,
2002). It has also been shown recently that CMS attenuates restenosis at the inlet and
outlet of the stent (Rolland PH et al., 2004). An end-to-end anastomosis would be an
example that one could use for a stented artery. It has been shown that compliance
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mismatch alone is not responsible for intimal thickening in an end-to-end anastomotic
region (Okuhn et al., 1989). Arterial injury, flow mechanics, stent design, etc are other
factors that have a great impact on intimal thickening.
Role of Other Mechanical Factors - Mechanical Stresses
Fluid mechanical shear stresses have a great influence on the vessel. As blood
flows through a vessel, it exerts a physical force on the vessel wall. This force can be
resolved into two principal vectors: (1) shear stress parallel to the wall, representing the
frictional force that the flow of blood exerts at the endothelial surface of the vessel wall;
and (2) tensile stress perpendicular to the wall, representing the dilating force of blood
pressure on the vessel wall. The dilating tensile stress is experienced by all layers of the
vessel wall, but the frictional wall shear stress is experienced only by the inner layer of
the endothelial cells of the vessel wall. Low me wall shear stresses with oscillatory
flow have been known to be the cause for atherosclerosis in arteries, while high wall
shear stress with laminar flow pattern has been shown to prevent atherosclerosis (Moore
JE Jr et al., 1994). In addition, the wall shear stress influence migration and proliferation
of endothelial cells (Hsu PP et al., 2001). Analysis of endothelial cell apoptosis (cell
death) showed preferential occurrence of apoptosis in the downstream region of the
plaque where the shear stress is low and unsteady compared to the upstream part (Tricot
et aL., 2000). Wall shear stress is known to affect the production of biochemicals by the
endothelial cells and the permeability of the arterial wall to macromolecules (Fabregues
et aL., 998) Thus the first vascular response to stenting, i.e. formation oft ombus may
be influenced by such factors as variations in blood and wall shear stresses and the
formation of vortices.
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Stent design also affects endothelialization. The doubling time for BC
proliferation was higher when the pitch of a coiled stent was much lower, i.e. when the
distance between coils was smaller ( agawa et aL, 2004). The doubling time was also
lower for BC proliferation upstream of the stent compared to downstream of the stent.
Thus, the flow patterns upstream and downstream of the stent and within the stent
influence platelet ,attachment and aggregation, cell migration and proliferation, and
protein and biochemical transport through the wall.
Role of Other Mechanical Factors - Flow Patterns
We need to note here that the flow patterns are dependent on stent design. Fluid
dynamics has been visualized since long using video microscopy and computational fluid
dynamics modeling (CFD). Fluid dynamic modeling is a useful tool as it helps in the
prediction of flow patterns without performing experiments, thus saving time and costs
for the investigator. In the next few paragraphs, we will see how CFD modeling has
helped us depict flow patterns in two-dimensions and three-dimensions. Two-
dimensional (2D) computational fluid dynamic (CFD) modeling of the protrusion of
individual stent struts into the flow field showed areas of flow stagnation ne the struts
(Berry et al., 2000). Prior research has shown that flow patterns did not change
drastically when using rounded stent struts or rectangular stent struts (Henry FS, 2000).
Two types of flow situations can take place in either rounded or rectangular 2D stent
struts, a separation region as flow hits the face of the strut and a reattachment region as
blood flows past the strut (see Figure 3). In the former, blood flowing down the artery
strikes the forward facing strut edge; this inhibits the forward movement of the blood
directly adjacent to the leading edge of the strut and therefore creates a separation zone
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(see Fig. 3a, Berry JL et al., 2000). In the latter, blood flowing over the top edge, the
momentum of the flow washes the blood past the edge of the step therefore creating an
area of flow separation adjacent to the trailing edge of the strut (see Fig. 3b, Berry JL et
al., 2000).
Mainstream flow
Inlet Outlet
(a)
(b)
(c)
Figure 3. (a) Fully recirculating region, (b) Partially recirculating at higher flow rates
and partially reattaching at lower flow rates, and (c) Fully reattached region. These
streamlines were seen at a flow rate lower than the mean flow rate.
The degree of flow separation is usually larger for the trailing edge than for the
leading edge. Based on the stent strut spacing (distance between two struts), the flow
could vary from being constantly recirculating to partially recirculating to constantly
reattaching between the struts (Berry JL et al., 2000). Here, the flow could be
characterized just based on one design parameter, ratio of the distance between the struts
L (from the center of one strut to the center of the next strut) to the strut height H. With
smaller stent wire spacings, less than 6 wire diameters, the stagnation regions from
adjacent struts merge together for the entire cardiac cycle, creating one single stagnation
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region (see Fig. 3c, Berry JL et aL, 2000). With larger stent wire spacings, greater than 12
wire diameters, the flow continuously reattached between the struts. In as little as a few
hours, the stent struts can be covered with thrombus therefore changing the ideal
geometry into a more complex one (Berry JL et aL., 2000). Thus, the use of forwad and
backward facing steps is only applicable in the acute stages of stent implantation and
maybe a few weeks after stent implantation.
Many three-dimensional (3D) models of actual stents have been constructed to
study the fluid flow patterns and wall shear stress distribution between the struts. They
also provide insight into which geometric properties are most important in influencing the
fluid dynamics of the stent. Steady state CFD modeling of Palmaz-Schatz stent showed
wall shear stress gradients (WSSG) being the highest around the regions of the stent
struts, at the stent inlet and outlet (LaDisa JF Jr. et aL, 2004). Theoretically those regions
could be susceptible to neointimal hyperplasia (LaDisa JF Jr. et aL, 2004). The number,
width, and thickness of stent struts imparted distinctive patterns of shear stress along the
wall with a realistic stent-to-artery deployment ratio of 1.1:1 (LaDisa JF Jr. et aL, 2004).
As the number of stent struts were increased, the area between the struts exposed to low
wall shear stress was greater (LaDisa JF Jr. et aL., 2004). If the number of stent struts
were maintained constant, but the stent-to-artery deployment ratio was increased, the area
between the struts exposed to low wall shear stress was greater (LaDisa JF Jr. et al,
2004). Increasing strut width may contribute to decrease in the area between the struts
exposed to low wall shear stress, but may cause greater vascular damage after
deployment. Increase in the stent-to-artery deployment ratio has been shown to alter
WSSG, the increase in WSSG was most prominent at the stent inlet (LaDisa JF Jr. et aL,
2004). Experimentally, the region of maximal cellular proliferation has been associated
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with high wall shear stress gradients (Liu SQ and Goldman, 2001). Smooth muscle cells
(SMC) have been shown to migrate to regions of low wall shear stress; they align in the
direction of flow in high shear stress regions and align perpendicular to the flow direction
in low shear stress regions (Liu SQ and Goldman, 2001). The SMC migration occurred
probably through endothelial cells modulation on the surface, which were also sensitive
to wall shear stress changes. Endothelial cell migration in a stented surface showed that
they migrate along the stent strut first and then orient themselves in the direction of flow
after reaching confluency (Walsh PW et al., 2000). Consideration of steady-state
simulations corresponding to average blood velocity give a reasonable estimate of the
average distribution of shear stress imparted on the wall of the stented vessels during a
single cardiac cycle (LaDisa JF Jr. et al., 2004). However full scale time dependent
simulations (corresponding to pulsatile blood flow) offer the benefit of visualizing
temporal changes in wall shear stress. Polygonal shape for the wall after stent
implantation gave rise to higher WSSG compared to circular shape for the wall (LaDisa
JF Jr. et al., 2004); polygonal shape of the wall was considered assuming that there was
circumferential stretching of the arterial wall after stent implantation. The degree of error
in the assumption was dependent on the geometry and the number of struts contained in
the stent. Antegrade iliac artery stent implantation in white rabbits showed that
neointimal hyperplasia was the greatest in the proximal and distal region of the stent, but
much lower in the middle region of the stented artery (LaDisa JF Jr. et al., 2005). It was
postulated that this increase in neointimal hype lasia at the proximal end of the stent is
due to increases in temporal WSSG (LaDisa JF Jr. et al., 2005).
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1.5.6 Flow effects on Platelet Deposition
Flow patterns differ through differing geometries. So is the platelet deposition at
various locations spatially in the geometry under consideration. The study of platelet
deposition in an expanded tube showed a peak in platelet adhesion in the vortex in which
the number density was appreciably greater than that downstream of the reattachment
point where fully developed laminar flow was established (Karino T and Goldsmith HL,
1979). At the reattachment point, platelet adhesion was a minimum. They attributed
platelet deposition to convective trap- of platelets through the instantaneous
streamlines. At the reattachment point, the platelet adhesion was a minimum. This may
be a result of the wall reaction rate and wall shear stress. If the wall reaction rate is
linearly dependent on the wall shear stress, the platelet flux is maximum downstream of
the stagnation point (David T et al., 2001). Aneurysm and stenosis flow models showed
greater platelet deposition in the regions of recirculation at the distal end for low
Reynolds numbers (Bluestein D et aL., 1996, 1997). Lowest platelet deposition has been
shown to occur within the smallest strut spacing (Robaina S et al., 2003).
Solid mechanical and fluid mechanical implications need to be considered before
designing producing an ideal stent design. Mechanical factors like wall shear stress and
circumferential wall stress seems to play a very key role in the restenosis process. Hence,
there is an increased need to study the role of mechanical factors in restenosis. Of
particular interest in our lab is the role of fluid mechanics within a stented artery. Platelet
deposition is strongly influenced by the blood fluid flow patterns. One of the first
vascular responses to stenting is thrombus formation (Gaasic JM et al., 2000), a process
initiated by blood platelets through the action of various enzymes in the coagulation
pathway (Macfarlane RG, 1964). The initiation stages of neointimal thickening may be
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related to the rate and extent of platelet deposition (Jeong MH et al., 1996). Hence, it is
necessary to study this first vascular response with differing stent geometries and the
influence of flow patterns formed within differing stent geometries.
1.6 Problem Statement - Study Objectives
Recently, platelet deposition in a stented chamber was shown by our group to be
dependent on the stent strut spacing (Robaina S et aL., 2003). The lowest platelet
deposition was measured in the model with the lowest strut-strut spacing. However, the
study did not provide information on the spatial distribution of platelets between the
struts as a result of changing flow patterns. No literature is available regarding the effects
of blood flow patterns on localized platelet deposition within the stented region either in
two-dimensions (2D) or three-dimensions (3D).
We postulate that the medium through which activated platelets attach to the wall
are a function of the instantaneous streamlines that depict the fluid flow pattern. Hence,
platelet flow and attachment is convection driven. This study focusses on the dynamics of
blood flow and its effects on the platelet deposition near stented region in the acute stages
of stent implantation. Two dimensional (2D) stent models are selected to simulate cases
of constant recirculation of blood flow, constant reattachment of blood flow, and
inte ittent reattachment of blood flow between individual stent struts. The platelet
deposition is quantified at different times between two individual stent struts. The
advantage in the 2D study was that stent design could be characterized just based on one
single parameter, the ratio of the distance between the strut centers (L) to the strut height
(H). The 2D study provides insight on platelet deposition at specific regions of disturbed
flow in the stented section. The limitation in the 2D study is that the geometry is simple
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and does not simulate the in vivo behavior of the artery wall to platelet deposition or the
flow dynamics. Hence platelet adhesion studies within 3D stent models (currently
marketed stents) is performed to correlate their relationship to localized changes in flow
patterns. The dependence of platelet deposition on streamlines in 2D was useful to depict
platelet deposition patterns in the 3D study. Some of the research questions that we tried
to answer in this study are: How does blood flow dynamics affect platelet adhesion and
localization within stented regions in 2D? Is the localization dependent on the time
course of blood flow? Does wall shear stress pattern affect platelet deposition in 2D? If
so, how? How does blood flow dynamics affect platelet deposition and localization
within the stented region in 3D? Are the results and the pattern of localization similar or
much different from 2D? Where are the differences, where, how, and why do they exist?
Experimental in vitro work using fluorescently labeled platelets (described in
detail in Chapters 2 and 3) and computational work using computational fluid dynamics
(CFD) software (described in detail in Chapter 2 and 3) are performed in order to answer
the above questions. An in vitro flow system comprising of a peristaltic pulsatile pump,
reservoir, connecting tubes, compliance chamber, and a specially designed 2D and 3D
flow chambers (described in detail in Chapter 2 and 4 respectively) is used. Human blood
with fluorescently labeled platelets is subjected to physiologic shear stress flow
conditions of 10+/-5 dynes/cm2 . Thirty-minute recirculation runs are performed. Data is
collected using image capture software for later processing. To estimate the possible
locations of higher platelet accumulation and deposition in stented arteries, this study
focusses on the highly-resolved (~1 rn/pixel or ~5 prn/pixel) spatial distribution of
platelets in 2D or 3D stented surfaces respectively. CFD geometries are created by
digitizing the images obtained from exper mental studies and modeled under the
26
assumption of Newtonian, incompressible fluid with the density and viscosity of blood
(1060 kg/rn3 and 0.004 kg/r-s respectively). Flow patterns are extracted from the CFD
using the instantaneous streamlines. The platelet deposition at certain locations between
the struts of a stented artery is then correlated with these instantaneous streamlines.
The detailed, highly resolved spatial information from this study will elucidate the
exact mechanisms behind the variations in platelet adhesion. The results provide insight
into how stent design affects fluid mechanical factors, which in turn affect platelet
accumulation and attachment. Subsequent reactions of the artery wall, such as
inflammatory responses, smooth muscle cell proliferation, and long-term geometric
adaptations, while important to the overall development of restenosis, are beyond the
scope of this study.
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2 EXPERIMENTAL AND COMPUTATIONAL METHODS
2.1 In vitro Experiment
A parallel plate flow chamber (Fig. 4) was constructed for study of blood flow
over the 2D stent under physiological pulsatile flow conditions using fluorescently
labeled blood platelets. The flow chamber includes a lexan top plate, lexan bottom plate,
silicone sheet (from Sylgard 184 Elastomer, Dow Coming Corporation, Midland, MI) of
~0.25mm thickness and hydrophilized in 70% sulfuric acid, and a 2D stent model (Fig.
5).
Blood Flo w
Figure 4 hmatic (exploded view) of the in vitro test system
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Figure 5. Schemnatic of the 2D stainless steel stent. Images were taken at the inlet to the
first strut, the outlet to the last strut, regions between the 1st and 2 "d struts and between
the3 3rd and 4th struts; these regions were located at least 3mm away from the nearest edge
of the strut and are marked on the figure by a darkened rectangle.
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The 2D approach was taken so that the stent strut configuration can be defined by
only a single parameter, namely the ratio of the strut spacing, L (the distance along the
wall in the axial direction from the beginning of one strut to the next), to the strut height,
H. The 2D stent, manufactured from electropolished 302 stainless steel (New Jersey
Precision Tec ologies, NJ), was designed such that the effect of blood flow on platelet
deposition could be observed in all stent strut spacings simultaneously, in parallel. The
number of struts within each configuration was different so that the outlet to the last strut
(or downstream of the stent) remained nearly at the same horizontal position along the
flow direction. The three strut spacings have the following length to height ratios: 2.53,
4.0, and 7.0. A cylindrical tube flow chamber (Fig. 6) was constructed for study of blood
flow over the 3D stent under physiological pulsatile flow conditions using fluorescently
labeled blood platelets.
Flow
Figure 6. Schematic of the 3D stented cylindrical flow chamber.
The tube was made from silicone (from Sylgard 184 Elastomer, Dow Coming
Corporation, Midland, MI) of 4 diameter and ~m thickness and hydrophilized in
70% sulfuric acid, and 3D stent models (Fig. 7). Sylgard elastomer was chosen in order to
simulate the mechanical environment in and around the stented artery. The plain sylgard
is elastic. The region of sylgard with an implanted stent becomes rigid. Thus, the
compliance mismatch obtained in traversing from an elastic to a rigid section of an artery
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can be simulated in our experiments. The 3D stents, manufactured from electropolished
302 stainless steel, were designed by the company and are currently being marketed. All
stents when implanted into the sylgard tube produced a stent-to-artery diameter ratio of
1.2:1 (semi-expanded case), except the NIR stent which produced a stent-to-artery
diameter ratio of 1.5:1 (over-expanded case).
Wall stent:
Bx Velocity stent:
Aurora stent: Between
st s
Outlet
I~n1
NIR stent:
Figure 7. Schematic of 4 different 3D stent types that were tested for platelet deposition.
Thickness of the struts varied from 0.09mm to 0.16mm. In Aurora stent, regions where
images were taken are shown.
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Note that these are calculated values and do not come from experimental
observations. Unlike the 2D approach, the design of these stents were more complex.
There were 5 Wall stents, 5 Bx Velocity stents, 2 Aurora stents, and 4 NIR stents
available.
Platelets obtained from blood (150ml) of human volunteers were fluorescently
labeled with a nucleic acid stain mepacrine (Crewe KH et al., 1986). For 3D experiments,
1OmI of blood was sufficient. Blood withdrawal procedures on volunteers (who gave
informed consent) followed were in accordance with the ethical standards imposed on
human experimentation by the Institutional Review Board (IRB) at Florida International
University. 100 microliters of 10mM mepacrine stock was added to 150ml of blood
(100m1 of blood for 3D experiments). Mepacrine does not affect platelet function at such
concentrations (Matsui H et al., 2002). Platelet secretion of mepacrine after platelet
adhesion and activation is sufficiently limited in rate and extent that platelet fluorescence
does not decrease detectably under our experimental conditions.
An in vitro flow system (Fig. 8) comprised of a reservoir, a peristaltic pump
connected to a ction generator that maintained sinusoidal flow conditions, a
capacitance chamber, and the test section. Fluorescently labeled platelet blood was
maintained in a reservoir at 37 degree celsius. Blood with fluorescently labeled platelets
was pumped from the reservoir to a capacitance chamber that filtered out the high-
frequency spikes in flow originating from the peristaltic pump, yet allowed the 1.1 Hz
flow pulsatility to pass. The blood pulsated through the test section with a shear stress of
10 5 dynes/cm2 (flow rate 1125 562 mL/min (96 50 mL/min for 3D experiments),
mean A amplitude at 1,1 Hz), The flow rate was maintained by the adjustments on the
function generator. For the 3D experiments, the mean flow rate was maintained
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consistently, but the amplitude did fluctuate between lowest shear stress of 3 dynes/cm2
to highest shear stress of 17 dynes/cm 2.
Function Peristaltic Capacitance
Generator Pump Chamber
Flow
Temperature Controlled Transducer
Reservoir
- Test Section
Camera for Image
Microscope Capture
Computer for
storage
Figure 8. Schematic diagram of in vitro flow system. The system consists of a reservoir
maintained at 37 degree celsius, a peristaltic pump controlled by a function generator, a
capacitance chamber to filter out high frequency spikes, a flow probe to measure the
actual flow rate through the system, the 2D or 3D test section, and a microscope to
observe the fluid patterns and capture images on the computer for further processing.
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Depending on the type of experiment being performed, the test section was
changed to a 2D parallel plate flow chamber or a 3D cylindrical stented tube. These
values of shear stress corresponded to a nominal physiological pulsatile flow condition.
The mean Reynolds number was 100 (or 133) for 2D (or 3D) experiments respectively.
The flow rate was verified using a transit time ultrasonic flow transducer (Transonic,
Ithaca, NY). Flow conditions were imposed for a period of 30-40 minutes approximately.
The movement and adhesion of fluorescently labeled platelets were detected with
an inverted microscope (Nikon, FL) equipped with a mercury arc lamp. The inverted lens
was set to a magnification of 20x for 2D experiments and 4x for 3D experiments.
Realtime images were acquired digitally with a Qimaging camera (Retiga, FL) on a Dell
computer using image capture software (Streampix, Version 2.8.1, No ix, Inc., Quebec,
Canada). Because of the inverted lens, the direction of flow also appears inverted in all
the images stored in the computer. For each location and time point, 2 or 4 seconds of
images were captured at approximately 20 frames/sec or 12 frames/sec respectively. Data
collected from the 2D experiments included images from the fully developed flow region,
adjacent to the inlet of the first strut, between struts of the lowest spacing, between struts
of the intermediate spacing, between struts of the highest spacing, and adjacent to the
outlet of the last strut (see Fig. 5); these locations were at least 3mm away from the
nearest edge ofthe strut. Images were taen at v ious locations of the same strut spacing
and also at different time points over the 30-40 minute experimental run time. Sample
images tken between the struts of inte ediate spacing at 3 different time points are as
shown in Figure 9. Data collected from the 3D experiments included images from the
fully developed flow region, adjacent to the inlet of the first strut, between struts,
between connectors, and adjacent to the outlet of the last strut (see Fig. 7).
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(a)
c)
Figure 9. Sampie image taken between struts of intermediate strut spacing at 3 different
time points; (a) time zone 1, (b) time zone 2, and (c) time zone 3.
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The stent was placed at a distance of at least 8mm (L) from the inlet to allow for
fully developed flow; this distance was calculated based on the formula
L=006*Re*diameter. Though L was theoretically calculated to be 38mm, the
experimental value for inlet length was much lower. It has been shown previously that for
pulsatile flow, the maximum entrance length was the same as the entrance length for
steady peak flow (He X and Ku DN, 1994). Our CFD models showed that an inlet length
of 8mm was sufficient for fully developed flow under steady peak flow conditions (see
section 2.2 and Chapter 3 for more details). Images were captured at later time points
(>20min) over the 30-40 minute experimental run time for all 3D stent types except for
Wall stent. This was done because the 2D approach showed that time did not have a
significant effect on platelet deposition and moreover, we were always interested in later
time points. Sample images taken between the struts of Wall stent at 3 different time
points are as shown in Fig. 10. The run time was not extended beyond this time because
the adhesion of platelets appeared to plateau after this time (for most conditions, see
Chapters 3 and 4).
To reduce the variations in image intensity due to AC lamp fluctuations and
experimental section movement from pulsatile flow, the frames in each sequence that
were in focus were averaged using image processing software (ImagePro, Version 4.5.1,
Media Cybernetics, San Diego, CA). The light intensity from the mercury arc lamp also
decayed with increasing radial distance from the center. A custom written Matlab
program (Version 6.1, The Mathworks, Natick, MA) provided background corection to
the images from the stented region based on the image file from the flly developed flow
region upstream from the stent, where platelet deposition should be uniform.
36
Figure 10. Sample image tken between struts of Wall stent at 3 different time points: (a)
time zone 1, (b) time zone 2, and (c) time zone 3.
A 4 Ih order polynomial was fit to the light intensity distribution curve (averaged
perpendicular to the blood flow direction) of the image file from the fully developed
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region. The background correction was performed by dividing the light intensity at each
pixel location of the image file at the stented region by the averaged light intensity at the
same horizontal pixel location (along the blood flow direction) within the image but at
the fully developed flow region (as fit by the polynomial) at approximately the same time
point for the 2D experiments. This resulted in the normalized background corrected data.
The normalized background corrected data was then averaged along pixel lines
perpendicular to the flow direction (approximately 500 pixels in length). For the 3D
experiments, the background correction was performed by dividing the averaged light
intensity at each pixel location of the image file (80-100 pixels) at the stented region by
the averaged light intensity at the same horizontal pixel location within the image but at
the fully developed flow region (as fit by the polynomial). The shape and size of the
region chosen in the stented image for background correction was the same as that for the
inlet file at the fully developed region. The axial distance (along the flow direction) was
calibrated using a hemacytometer glass slide (lmmx1mm squares) placed inverted over
the inverted lens of the microscope. Thus, the spatial resolution obtained was
1.O56pm/pixel x 1. 05 pixel for 2D experiments and 5.236pm/pixel x 5.263p/ixel
for 3D experiments.
The background corre ed data at all time points were grouped into 3 different
zones: time<1 0mi (zone 1), time=1 0-2min (zone 2), and time>20min (zone 3) for all
2D experimental data and for 3D Wall stent alone. For the rest of the 3D stent types, we
plotted data at time>20min only. The normalized background corrected data from each
location measured within a particular time zone were averaged and plotted as a function
of axial distance (in mm). Wall stent has two stent geometries within its design as
indicated in Fig. 10 and corespndingly platelet deposition in the direction of flow and
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perpendicular to direction of flow were plotted from each geometry. From a total of 8
separate 2D experiments, and 16 separate 3D experiments, there were at least 15 samples
for averaging in each time zone. The different time zones were created to see if time had
a significant effect on platelet deposition.
Using SPSS (SPSS Inc., Chicago, IL, Version 10.0), two-way ANOVA (with
respect to time zones and locations along the intensity curve) with a Dunnett C post-hoc
test was performed to determine the statistical significance of the results. Differences
achieving p<0.05 were considered significant. Quantitative information on percentage of
higher or lower platelet deposition was obtained bas on significance levels as well as
the observed means.
After each experiment, the flow chamber was disassembled; the blood and tubing were
removed and discarded as a biological hazard; the chamber, the stent, and the reservoir
were cleaned with bleach and soap.
2.2 Computational Fluid Dynamic (CFD) Simulation
We developed generic parametric three-dimensional (3D) models initially to study
differences in platelet adhesion in each of those models. But the idea of using currently
marketed in vivo stents (see Fig. 7) came later. Accordingly, we describe the methods
used in the generic 3D simulation models first (since this is published data). Then we
could transpose the same to the currently marketed stents, with additional simulations and
explanations wherever necessary. Some of the results from generic 3D parametric stent
models were helpful for certain explanations with the currently marketed stents.
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2.2. Parametric Comparison of 3D Generic Stented Models
We developed 3D CFD models to study the blood flow patterns in stented arteries
under low and high flow conditions using computational fluid dynamics. Our simulations
have provided high-resolution flow data in the ne strut region of steteed arteries under
pulsatile flow conditions. My contribution to this work includes (1) performing reversed
flow profile simulations, (2) comparing all mechanical factors in the parametric models
between forward and reversed flow profile simulations, and (3) write-up of the paper.
Our models allow for a parametric variation in strut geometry, and four different stent
designs were examined. Rather than representing specific designs currently on the
market, we have chosen to evaluate a "generic" model of a stent in order to provide more
generally applicable design criteria. Our evaluation criteria were specifically developed
to quantify flow stagnation and WSS, in order to help us interpret platelet adhesion and
endothelial cell growth in the near strut region of the arterial wall.
Computational domain: The current state-of-the-art stent designs used in the
clinical setting are highly complex 3D "wire-mesh" type structures. The fundamental
component of a stent, or the wire from the "wire mesh", is known as a strut. Each stent
design has a specific strut configuration.
Our intent was to simulate the detailed flow characteristics of the complex 3D
geometry present by a stented artery. Our computational domain was chosen based on
the following two considerations: 1) we desire to minimize the computational expense of
our simulations and 2) we would like to provide the most representative model that best
captures the flow characteristics from each stent design. Hence we adopted a 3D
Cartesian geometry that signified the near-strut portion of the stented artery (Fig. 11 a).
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The mainstream flow direction is along the Cartesian Z-axis, and the cross-stream
direction is along the Cartesian Y-axis.
(a)
Connector
Strut (b)
Figure 11. (a) computational domain and (b) computational mesh of one of the stent
models used in XZ plane (see text).
A fUll 3D pulsatile computational flow simulation considering the entire stented
artery flow domain would be computationally expensive and is not warranted. With that
in mind, we have taken advantage of the repetitive strut pattern and the inherent
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symmetry built into these patterns. Our model therefore consists of only two adjacent
struts along the axial (flow) direction with the circumferential direction restricted by strut
pattern symmetry. For simplicity, the computational domain in the cross-stream direction
was flat, rather than curved, since the height of the stent strut is 0.15 mm, or 8% of a
18mm a rerial radius. Furthermore we have emphasized the region closer to the wall of
the stented artery. The height of the computational domain above the artery wall was
1 5mm. To achieve fully developed flow (flow without strut influence), and to avoid
adverse effects from the boundary conditions, the inlet and outlet leng proximal and
distal to the stent struts were Lin=12mn, Lot=3mm for high flow (or Lin =12mm,
L,,t=l2 for low flow). Equal length of inlet and outlet was used because the inlet
velocity has negative values under low flow conditions.
The parametric model of the strut considers only three design parameters (strut
interspacing (h, or axial strut pitch), spacing between concave to convex portion of the
same strut (f, or "amplitude"), and radius of curvature of the strut (r) with the strut cross-
section fixed (0.15mm by 0.15mm square) as shown in Fig. 12. Four stent models
(models a,b,c,d) were studied (Fig. 12). It should be mentioned that use of existing
commercial stent geometries may have allowed direct comparison with human clinical
trials. However, it was more desirable to vary the geometry in a parametric fashion for
future stent designs. The configurations used in this study do reflect the design of some
commercial stents. The domain dimension of W (width of the computational domain)
was kept constant; while these three parameters were changed to make new strut designs.
Another criterion for design was the presence or absence of a longitudinal connector
between the struts in our models. The computational domain was discretized using a
structured hexahedral mesh (Fig. 11 b). The number of cells ranged from 162924 to
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279083, depending on strut design parameters (l, f, and r) and on presence or absence of
connector. Mesh independence was determined from convergence (<4.6%) of the axial
WSS or the strain rate along the length of the stented model (b).
Distal base
Distal apex Connector
oximal base
N rrow band
Proximal apex
(a) (b) (c) (d)
h=1.8mm h=1.8mm h=3.6mm h=3.6mm
f=0.9mm f=1.8mm f=1.8mm f=3.6mm
r=.45mm r=0.9mm r=0.9mm r=0.9mm
Figure 12. Four parametric models of stent struts geometries. (a) h=1.8mm, f=0.9mm,
r=0.45mm, (b) h=1.8mm, f=1.8mm, -09 (c) h=3.6mm, f=l.8mm, r=0.9mm, and (d)
h=3.6mm, f=3.6mm, r=0.9mm.
Governing equations: The blood flow was modeled as a homogeneous
Newtonian viscous incompressible fluid using the 3D Navier-Stokes and continuity
equations with blood density of 1060 kg/ 3 and dynamic viscosity of 4.0 mPa s.
Boundary and initial conditions: The artery and strut wall boundary regions were
assumed to be rigid and defined with a no-slip velocity boundary condition. Both the
side-wall and bottom-wall of the computational domain were treated as symmetric
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boundary conditions (normal velocity vanishes at boundary). A fully transient (pulsatile)
loading was applied to the computational domain as velocity driven conditions. The inlet
boundary condition was described by a spatially uniform and transiently varying velocity
profile, as follows:
VIn"e =0, VInle = " at+bsin(wt) 5 (1)
The inlet flow parameters (a, b, d co) were predetenmined in order to provide the
following flow characteristics observed in arteries (Ku DN et aL, 1985; Moore JE at aL,
1995): 1) a typical high flow representing a normal level of flow in a relatively straight
artery (nominal shear stress of 10 5 dynes/cm2 (in SI, ldyne/cm2=0.1N/m 2 ), mean
amplitude); and 2) a low flow condition that may be present at the inner walls of curved
sections or in arteries with poor run-off (2 10 dynes/cm 2). The frequency of this
sinusoidal velocity profile was 1.1 Hz, co esponding to a hea rate of 70 beats/minute.
Note that the low flow condition provides shear stress reversal even in the absence of
struts whereas the high flow does not. The WSS of atherosclerotic areries varies
depending on the anatomical location, local geometry, and the distal resist ce. In this
study, we choose to focus only on the stented section, using different boundary
conditions on flow to account for these other variations.
For a heart rate of 70 beats per minute, the resulting inlet velocity parameters
under nominal flow can be evaluated as follows: 1) for high flow; a=12.5 cm/sec, b=6.25
cm/sec, and -7.331 rad/sec and 2) for low flow; a=2.5 cm/sec, b=12.5 cm/sec, and
-=7.331 rad/sec. For the high flow condition, Reynolds number (Re)=240 and
Womersley number (Wo)=5. For the low flow condition, Re=50 and Wo=5.
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The outlet flow boundary was described by a spatially and transiently uniform
pressure distribution of 0. The computational solutions were fully transient unsteady
simulations with the initial conditions for the entire domain determined from a steady
state simulation using mean inlet velocity boundary conditions (i.e., 12.5 cm/sec for high
flow and 2.5 cm/sec for low flow).
Criticalflow solution parameters: In order to examine the effects associated with
the varying strut patterns from each stent design, we have evaluated the following two
blood flow parameters: I) a flow separation parameter ($) and 2) a WSS parameter.
The flow separation parameter quantifies the fraction of time, with respect to one
period, that flow at some point on the arterial wall is separated from the mainstream flow
(i.e., stagnation or re-circulation), as follows:
Ts
T
where # is the separation parameter, Ts the amount of time that flow is separated from the
mainstream, and T the total time of one period (O.8571 sec). Notice that the separation
parameter is only a spatially varying quantity. We have defined flow separation as
occurring when the wall shear has the opposite sign from the mainstream flow. For our
analysis, only the axial WSS is used for the calculation of separation parameter. Hence
flow separation is equally represented by either forward or reverse (based on velocity
profile alone) mainstream flow and thus the separation parameter will necessarily vary
from 0 to 1. A value of 0 implies no flow separation, and a value of 1 implies constant
flow separation throughout the entire flow period (re-circulation or stagnation). The
separation parameter for the high flow was calculated as given in above equation (2); the
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separation parameter for the low flow was adapted to account for the natural shear stress
oscillation as follows:
Tp (pos) + TN (Oneg (
T
where #,, is the separation parameter during the time of forward mainstream flow Tp,
#neg is the separation parameter during the time of reverse mainstream flow TN, T is the
total time of the flow cycle (= Tp + TN). WSS is both a spatially and temporally varying
quantity. We have normalized the WSS with respect to WSS under nominal flow
conditions (i.e., flow without strut influence). The normalized WSS was calculated as
follows:
WSSxl nonnal ~yz ~---jj=----
oyz
where WSSaxiai is the normalized axial WSS taken along the direction of flow, , is the
axial fluid shear stress, and the nominal oyz is the normalization factor. ,, is the
transverse WSS perpendicular to the flow direction.
Simulations conducted: Our parametric model was used to examine the flow
characteristics of four different stent designs due to variation in their strut patterns, as
shown in Fig. 12. The governing equations for the blood flow were discretized using the
finite volume method and solved using the CFD-ACE flow solver (CFDRC, Huntsville,
AL) with a minimum residual of le-18 and a convergence tolerance of le-4 for the
velocity and pressure variables. The upwind scheme (and SIMPLEC algorithm) was used
for solving for velocity in most of our models, with a default inertial relaxation
coefficient of 0.1 and linear relaxation coefficient of 1.0 for both pressure and velocity.
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For solving the stent model (a) with low flow condition, a 2 "d order upwind spatial
discretization for velocity was used with 20% blending, a pressure correction of 0.2, and
a linear pressure relaxation coefficient of 0.8 was used due to difficulty in converging the
model with the former solution and relaxation scheme. The time step size was fixed at
.571 msec, or 100 steps for each cyclic period of the inlet velocity function (or7.331
rad/sec). All simulations were carried out from time point 5 to time point 105 in order to
obtain one complete flow cycle. Time step independence was determined from
convergence (<5%) of the mean axial WSS. At some locations within the stented
chamber, the mean WSS deviations were >10%; however the WSS in these regions were
very low (of the order of <0.01 dynes/cm2 and negative); this was observed only at the
time points when the direction of velocity changed. All simulations were carried out until
a time periodic flow convergence (<10%) was established between successive oscillatory
periods, typically just over 1 flow cycle.
The computational simulations of each of these four stent designs were conducted
on a Dell Workstation PWS620 x86 family 6 dual processor, 1GB RAM, and 150 GB
hard disk. Each of these simulations typically generated 800 MB of data d required 120
CPU hours to complete. Also note that simulations using each of these stent designs were
carried out (a) with and without connector between struts, (b) under high and low flow
conditions. Therefore, a total of 16 different simulations were performed. Since we are
interested in the flow characteristics adjacent to the wall, we have chosen WSS as our
convergence criteria since it is more restrictive th using the primary domain variables
(V, V, Vz, and P).
Axial and transverse WSS from each model were extracted using CFD-IEW. Data
from 5th to 10 5 th time points (including all time points in between) were used to represent
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1 complete flow cycle (see Fig. 13) and extracted along the flow axis (in Fig. 14a), at a
distance of 0.25H, 0.5H, 1H, 21, ... , 101H (H is the height of the strut) respectively from
the left edge of the connector. The WSS data at 0.25H and 0.5H especially provided
quantitative information on flow characteristics in the region next to the connector. Two-
dimensional contour plots of mean, maximal, minimal axial and transverse shear stresses,
and separation parameter were generated for all models (using Axum 7, Insightful Corp.,
Seattle, WA). Contour plots included the right half of the connector, which were
generated using symmetry.
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Figure 13. (a) The velocity profile curve (also shows time point tI (3O* time point)) and
the corresponding WSS for low flow condition and (b) The velocity profile curve (also
shows time point ti (3 0 'h time point)) and the corresponding WSS for high flow
condition.
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references (Robaina S et aL, 2003; He Y, Masters Thesis, 2002). In short, the fluid (ie.
blood) was considered incompressible and Newtonian, and the velocity profile used was
the same as that in Fig. 13a. The Reynolds number (Re) was 100 and Womersley number
(Wo) was 2.1. A 3D flow model similar to the 2D stent geometry (i.e. a rectangular
parallel plate) used in the experimental setup was used to determine the entrance length
from where fully developed flow would occur; the entrance length was 3.8cm as
predicted by the simulation. A 3D flow model of a rectangular parallel plate along with
the stent was used to estimate the edge effects; a minimum of 3mm distance was
maintained from the edge while taking images of platelets between the stent struts in 2D
stent (see Fig. 5).
For the 3D stents, the geometrical details were obtained based on digitizing
images after the experiment, with the stent in the expanded state. The 3D stent geometry
modeled was planar because (1) we were interested only in the near-wall phenomena and
(2) the strut height was <8% of the arterial radius. Moreover, it has been observed that
there is circumferential and axial stretching of the arterial wall after stent implantation
(LaDisa JF Jr. et al., 2005), which further decreases the ratio of strut height to arterial
radius. The stent-to-artery diameter ratio was 1:1 for the CFD models. This value is
different from those calculated and reported previously because no stagnation zones were
observed at the inlet and outlet of the stent during the time of experiments. The stent-to-
arte diameter ratio was 1.5:1 for the NIR stent CFD model alone because huge
stagnation zones were observed at the inlet ofthe stent experimentally.
The structured grid was used to mesh the 3D models, for example, see Figures
15a and 15b. Even for the 3D stent models, blood was considered as an incompressible
viscous Newtonian fluid d the velocity profile used was the same as that in Fig. 13a.
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Figure 15. (a) Computational structured grid domain of stent type (b); (b) computational
structured grid domain of stent type (c) as modeled in CFD.
The flow parameters calculated for the 3D stents were Re= 130 and Wo=2.8. Inlet
and boundary conditions were applied on the model, same as in section 2.2.1. Mesh
independence was determined from convergence (<10%) of the axial WSS or the strain
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rate along the length of the stented model. See Figures 16a and 16b for mesh
independence obtained in Bx velocity stent and Wall stent models. Note that mesh
convergence was obtained for most of the length along the stented model, except at very
few locations very close to the strut. The spatial resolution of each data point was
0.046mm.
Grid convergence for Bx Velocity stent
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Figure 16. Mesh convergence for (a) Bx Velocity stent and (b) Wall stent.
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The 3D models are very complex with curvatures of struts presented at various
locations, hence it was necessary to cut short the optimal number of grid points for the
models without compromising on the fluid dynamic predictability. The NIR stent model
was created by first obtaining mesh convergence on a 1:1 stent-to-artery diameter ratio
model and then using the same number of grid points to expand into a 1.5:1 stent-to-
artery diameter ratio model. The over-expanded NIR stent model was simulated under
steady flow physiological mean shear stress of 10 dynes/cm2
The experimental entrance length of 8mm was verified by simulating steady flow
condition of physiological shear stress of 10 dynes/cm2 in Aurora stent (see Fig. 17).
Wall shear stress along flow direction
E r m a n
16
40
Fig, ra 17. Simulation showing that anentrance ' ,}gth of 'rmwssfiin o
experimental purposes.
The instantaneous streatlines were extracted om the numerical results using
CFD-VIEW for comparison with the platelet deposition in this study.
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3.1 Platelet Deposition and Computational Results of 2D Stented Models
Platelet deposition patterns and their relationship to flow patterns in the 2D
stented region are illustrated in Figures 18-22. Platelet deposition patterns at regions
adjacent to the first strut, between struts of smallest spacing, largest spacing, and
intermediate spacing, and finally adjacent to the last strut respectively were measured
(see Figure 5 for locations). All differences noted in this section are statistically different
with p<=O.O5.
Inlet flow leading up to the first strut separates from the bottom wall just before
the strut, producing a corner region of recirculation (Figure 18). Platelet deposition was
28.6% higher at the region of recirculation (location B) adjacent to the first strut
compared to the region of no flow disturbance upstream (location D), and 26.4% higher
than the deposition in the corner flow region (location A). The point of separation
(location C) had 50.5% lower deposition compared to the region of recirculation (location
B). The point of separation (location C) had 14.6% lower deposition than the region of no
flow disturbance (location D), but was not statistically significant. There was no
significant difference in platelet deposition between the three different time zones.
For the smallest strut spacing, a region of recirculation between the struts
persisted t oughout the entire flow cycle (Figure 19). The region of maximurn platelet
deposition at the center of this recirculation (location B) was 46% higher than regions
very close to the struts (with very low platelet deposition, locations A & C). The three
different time zones were again not significantly different from one another.
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Figure 18. (a) Average normalized platelet deposition at the inlet to first strut plotted as a
function of distance (in mm). (b) Path of instantaneous streamlines at minimum flow (Q
represents the flow rate) at the inlet to first strut. Locations A, B, C, and D correspond to
various flow regimes near the wall. Location A is the corner flow region; location B is
the center of the recirculation region; location C is the average point of separation
between minimum and maximum flow (varies up to an order of 0.035mm); and location
D is the region of flow parallel to the wall far upstream.
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Figure 19. (a) Average normalized platelet deposition between struts of that smallest strut
spacing plotted as a function of distance (in mm). (b) Path of the instantaneous
streamlines at minimum flow (Q represents the flow rate) between the struts of smallest
spacing. Locations A and C define the corner flow region and location B is the center of
the recirculation region.
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The largest strut spacing provided ample room for the flow, that had separated off
of the upstream strut, to reattach to the bottom wall distal to the upstream strut before
forming a separated flow region proximal to the downstream strut (Figure 20). The point
of separation (location C) and reattachment (location G) had 24.5% and 41.5% lower
deposition compared to the regions of recirculation proximal and distal to the strut
respectively (locations B and H). The platelet deposition in the comer flow regions very
close to the struts (locations A and I) were 35% (72%) lower than the region of
recirculation proximal (distal) to the strut (locations B and H again). Between points D
and F the flow remains parallel to the bottom surface and the platelet deposition
decreases almost linearly from point F to D in the direction of flow. Platelet deposition at
point D was 22.8% significantly lower than the platelet deposition at point F. The three
different time zones were once again not significantly different.
The intermediate strut spacing produced a flow that was reattaching at minimum
flow, and recirculating at maximum flow (Figure 21). The platelets deposited relatively
homogeneously in this scenario, compared to the smallest and largest strut spacing. The
platelet deposition at the center (location C) was 35-45% higher than the comer flow
regions very close to the struts (locations A and E). The platelet deposition in the
predominant distal recirculation region (location D) was 8.7% higher than in location C.
In this case alone, the platelet deposition at the third time zone was significantly higher
than the deposition at the first and second time zones.
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Figure 20. (a) Average normalized platelet deposition between struts of largest spacing
plotted as a function of distance (in mm). (b) Path of instantaneous streamlines at
minimum flow (Q represents the flow rate) between struts of largest spacing. Locations A
and I define the corner flow regions very close to the strut; locations B and H are the
center of the recirculation regions; locations C and G are the points of separation and
reattachment (varies up to an order of 0.04mm and 0.07mm respectively); location E is a
point where the flow is parallel to the bottom wall distal to the recirculation regions; and
locations D and F are points just upstream and downstream of the separation point and
reattachment point respectively.
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Figure 21. (a) Average normalized platelet deposition between struts of intermediate
spacing plotted as a function of distance (in mm). (b) Path of instantaneous streamlines at
minimum flow (Q represents the flow rate) between struts of intermediate spacing. c)
Path of instantaneous streamlines at peak flow between struts of intermediate spacing.
Locations A and E denote the corner flow regions very close to the strut; location C is the
center between the struts; locations B and D denote the recirculation regions.
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Flow separates once again off the last strut, producing a separated recirculating flow
region similar to the inlet strut but, of course, opposite in direction (Figure 22). Similar
to the other cases, the platelet deposition at the region of recirculation (location D) was
24.8% higher than the point of reattachment (location C) d 98% higher than corner
flow region very close to the strut (location E). The platelet deposition downstream of the
strut (location A) was 10.7% lower than location B, just downstream of the reattachment;
the platelet deposition was decreasing in the direction of flow similar to that found in
1agest strut spacing. The platelet deposition at the point of reattachent was 19.9%
lower than location B, just downstream of the reattachment.
3.2 Computational Results of 3D Generic Stented Models
Many of the principle flow characteristics can be understood by analyzing the
instantaneous streamlines. The stent strut geometry caused deviations in near-wall
streamlines away from the axial direction that roughly followed the strut shape.
However, the degree of deviation depended on the flow conditions. Under low flow
conditions, the orientation of the streamlines changed in accordance with the reversed
flow velocity profile. There was less change in strearline direction under high flow
conditions. Streamlines showing flow disturbance at time point tl (see Fig. 13a & 13b,
refer to the 30 time point) for the stent model (b) with connector, under low flow (Fig.
14b) and high flow (Fig. 14c) conditions are shown (see Chapter 2, section 2.2.1 for these
figures). At time point tI, the velocity has already started to increase (from the lowest
value, which occurs at the 2 5 th time point). The disturbance in flow was the least in the
regions nearest and farthest from the connector, where the strearlines were parallel and
in the axial direction.
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Figure 22. (a) Average normalized platelet deposition at the outlet to last strut plotted as
a function of distance (in mm). (b) Path of instantaneous streamlines at minimum flow (Q
represents the flow rate) at the outlet to the last strut. Location A defines a region far
downstream of the reattached point; location B is the point just downstream of
reattachment point; location C is the point of reattachment (varies up to an order of
0.07mm); location D is the center of the recirculation; and location E is the corner flow
region very close to the strut.
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The streamlines converged at the proximal end of the concave portion of the arc
of the strut and diverged from the distal end of the convex portion of the strut. The
streamlines within the struts were most parallel (in the direction of flow) for the stent
model (d). The streamlines did not vary noticeably between models with connectors and
those without connectors.
Under high flow conditions, the mean axial WSS in the stent model (a) with
connector under high flow conditions was only restored to 50% of the nominal value for
much of the area between the struts. The contour plot shows that the mean axial WSS
decreased gradually on approaching the first strut (Fig. 23a), The low mean axial shear
stress region distal to the first strut was larger than the region proximal to the second
strut. This large mean axial shear stress was closer to the second strut. The large mean
shear stress region was divided due to the presence of the connector. At a position 0.66
n proximal to the second strut, the largest mean axial WSS was restored to 80% of the
nominal value. The mean transverse WSS was dominant along the oblique parts of the
strut, i.e. at regions proximal to the first strut, between struts, and distal to the second
strut (Fig. 23b). The struts are at angle to the main flow and thus cause local changes
in flow direction. As a result, the flow near the struts is not limited to the axial direction.
The mean transverse WSS was very small ne the connector since the connector is
aligned parallel to the main flow. Flow separation occurred around the entire length of
the struts, most extensively at the distal end of the struts oriented at angles to the main
flow direction (Fig. 23c). Recirculating flow for most part of flow cycle (characterized by
separation parameter larger than 0.5) existed adjacent to the apex and base of the struts.
Separation parameter was <0.1 (approximately 0 in this case) between the struts
indicating flow reattachment for most part of the flow cycle.
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The axial shear stress for the stent model (a) without connector under high flow
conditions was continuous between the struts (Fig. 24a). Fig. 24b shows the tr sverse
shear stress variations, similar to that of Fig. 23b. The contour plot of the separation
parameter showed much less flow separation distal to the second strut, at regions closer
to the base (Fig. 24c).
The largest rean axial shear stress between the struts of stent model (a) with
connector under lowflow conditions was located just proximal to the second strut within
0.42mm (Fig. 25a). This distance was 36% shorter for the model under low flow than
high flow. The mean transverse shear stress was largest distal to the strut (Fig. 25b). The
contour plot of separation parameter for the model with connector (Fig. 25c) showed
recirculating regions at the apex and base of the first and second struts. Flow separation
with separation parameter of 0.2-0.3 was distributed proximal and distal to the struts, and
along the length of the struts.
The narrow bad between the two rows of struts (refer to Fig. 12 for narrow band)
in the stent model (1) with connector under low flow conditions resulted in more of a
reduction in the mean axial shear stress (Fig. 26a). Varying the strut parameters f and r
provoked changes in the mean transverse shear stress. At the vicinity of the narrow band,
the mean axial shear stress is very low. However, in this region, the mean transverse
shear stress is very high (Fig. 26b) and higher than that of the stent model (a) (by -30%
for the region between 4H and 7H). Large mean tr sverse shear stress existed at regions
proximal to the proximal apex, the narrow band between the struts, d distal to the distal
base.
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Flow separation occurred at the areas near the apex and base of the struts. The
separation parameter of 0.2-0.3 was found at steeper sections of the struts (specifically
extending from the concave, convex sections of the strut inwards, outwards respectively,
see Fig. 26c).
Increasing the longitudinal strut spacing h to 3.6mm increased the degree to
which the axial WSS was restored between the struts in stent model (c). For high flow,
the largest mean axial shear stress region between struts was divided into two (Fig. 27a).
The narrow band was not obvious because of the larger strut spacing. The large mean
transverse shear stress regions between struts were connected through a low mean
transverse shear stress region of 1.2 dynes/cm2 (27% of the largest mean value) for high
flow (Fig. 27b), and -0.2 dynes/cm2 (12% of the largest mean value) for low flow. The
area of flow separation at the apex and base of the struts in this model appeared smaller
to that seen in stent model (b) (Fig. 27c). Separation parameter (>0.5) in the former was
only 30% of the latter.
The strut parameter f was increased to 3.6mm, which caused the connectors
connecting the arcs of the struts in stent model (d) to be more aligned to the flow axis. A
narrow band, narrower than the stent model (b), divided large mean axial WSS into two
regions, where the flow had almost recovered (Fig. 28a). Large mean tr verse shear
stress was located at the narrow band, and their locations were similar to that of stent
model (b). For high flow, the flow separation seemed to exist more distal to the struts
(Fig. 28c).
The largest mean axial shear stress restored between the struts was at least 80% of
the nominal value; hence we are interested in the average of the mean axial shear stress
between struts. Fig. 29 shows the average mean axial shear stress between the struts was
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largely restored to 67% and 60% of the nominal value under high flow, low flow
respectively for the stent model (c) with connector.
The mean transverse shear stress between struts represents the level of
interference to flow. Fig. 30 shows that with increase in strut parameter f from 0.9mm to
1.8mm (accompanied with increase in strut parameter r from 0.45 to 0.9 ), the
mean transverse shear stress increased by 14-18% due to the narrow band between the
struts as seen in the contour plots. However, when the strut parameter h was increased
from 1.8mm to 3.6mm, the mean transverse shear stress decreased by 38-40% due to
increased strut interspacing. But when f was increased from 1.8mm to 3.6mm, the mean
transverse shear stress did not significantly increase in the presence of the narrow band
between struts. It is interesting to note that the me transverse shear stress for the model
without the axial connector is eater by 8% during high flow and is smaller by 8%
during low flow.
A greater percentage of the area between the struts had a separation parameter
<0.1, indicating fluid reattachment to the wall during >90% of flow cycle. For more
quantitative evaluation, we analyzed separation parameter >0.5, which indicates flow
recirculation for at least 50% of the flow cycle. When the strut parameter h was increased
from 1.8mm to 3.6mm, Fig. 31 reveals a drastic decrease in regions of recirculation, due
to greater strut interspacing, by 57-60% under high flow and by 66-68% for low flow.
When f was increased from 1.8mm to 3.6mm with the same r, there seemed to be
relatively small increase in separation parameter.
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When the strut parameter f was increased from 0.9mm to 1.8mm (also increasing r from
0.45mm to 0.9 ), the area in which the separation parameter ranged from 0.1-0.5
decreased (Fig. 32), indicating increased fluid reattachment to the wall. When the strut
parameter h was increased from 1.8mm to 3.6mm, the area in which separation parameter
ranged from 0.1-0.5 further decreased by 50%. When f was increased from 1.8mm to
3.6mm, there was much less change in separation parameter. The area in which the
separation parameter ranged from 0.1-0.5 was relatively higher for all the models under
low flow compared to high flow, whereas the separation parameter >0.5 was higher for
only 2 of the 4 models with connector. From the contour plots, flow stagnation regions
occurred at the proximal and distal portion of the apex and base of the strut and
separation parameter of 0.2-0.3 were observed along the length of the strut for low flow.
In brief, analysis of strut parameters f, and r shows: (a) increasing h or
decreasing f increased restoration of axial shear stress between the struts; (b) increasing h
decreased the transverse shear stress; (c) increasing r and f reduced restoration of axial
shear stress between the struts, and increased the transverse shear stress; (d) regions of
recirculation (for most part of flow cycle govemed by separation parameter >0.5) were
greater for the high flow (except the stent model (b) with connector); under low flow, it
remained the same as that under high flow for models (b) and (d); (e) regions of flow
reattachment (for most part of flow cycle governed by separation pa rameter 0.1-0.5) were
larger under low flow for all models; (e) models without the axial connector showed
increased restoration in axial shear stress and reduced separation parameter compared to
models with the axial connector.
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3.3 Platelet Deposition and Computational Results of 3D Stented Models
The mean axial wall shear stress and separation parameter were computed for Bx
velocity and NIR semi-expanded stent models and is as shown in the Figures 33 and 34
respectively. Fig. 33 shows that axial wall shear stress was restored around most of the
region between the struts except around the connector region. The mean wall shear stress
at the laminar flow region before the stent was 9.72 dynes/cm2 . Regions of stagnation
seem to be located mostly within the connector region and distal or proximal to the
convex or concave end of the strut respectively. These plots are useful to analyze the
regions of stagnation and thus be able to observe carefully at those stagnation regions at
the time of the experiment. The depiction of flow patterns within the stented region using
instantaneous streamlines can also give information on the stagnation zones. This tool is
used in the remaining of the results and the discussion sections.
Platelet deposition patterns and their relationship to flow patterns in the 3D
stented region are illustrated in Figures 35-47 (these figures follow with the results as
presented in the paragraphs below). For all stent types, the platelet deposition patterns at
regions adjacent to the first strut, between struts, between connector regions (it exists),
and finally adjacent to the last strut respectively were measured. All differences noted in
this section are statistically different with p<=0.05.
Wall Stent: Inlet flow leading up to the first strut separates from the bottom wall
just before the strut, producing a corner region of very low platelet deposition near the
intersection of the two struts of Wall stent (Fig. 35).
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Figure 33. Axial wall shear stress variation and separation parameter variation within
the stented geometry of Bx Velocity stent.
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Figure 34. Axial wall shear stress variation and separation parameter variation within the
stented geometry of NIR stent.
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Platelet deposition was 24% lower at the region of intersection of the struts
(location A) compared to a region nearby (location B). Location B had 65% higher
platelet deposition compared to the region of no flow disturbance (location C). There is
more platelet deposition at the proximal portion of the strut (location D) compared to the
distal portion of the same strut (location E) as seen in Figure 35a. Platelet deposition
curves showed no significant difference with respect to time. Figure 35c shows the path
of streamlines carrying activated platelets just before the first strut; there is mainstream
fluid coming in from underneath the strut as well as fluid coming between the wall and
the other cross-over strut that reattach; note that there is no region of recirculation here.
Platelet deposition between the struts was plotted both in the direction of flow and
perpendicular to the direction of flow (see arrows in Figure 36a). Platelet deposition was
30% lower at regions close to the intersection of the two struts (locations A or D)
compared to the center (locations B or C) as seen in Figure 36b. Deposition was higher
(location B) closer to the distal portion of the strut by 34% compared to further
downstream (location C) and decreased linearly (location C) in the direction of flow.
Perpendicular to the flow direction (Figure 36c), the platelet deposition was higher at the
center (location B) by 43-80% compared to regions close to the strut (locations A or C).
Platelet deposition curves showed no significant difference with respect to time. The path
of streamlines in the whole region between struts (Figure 36d) with flow coming in and
out of the gaps between the wall and the strut are shown; close-up view of streamlines
distal to the struts are similar to streamlines from Figure 35c; close-up view of
stream.lines proximal to the struts are similar to streamlines from Figure 37c. Based on
the inclination of the struts to the flow, two different geometries have been identified
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(Figure 36a); platelet deposition curves for geometry 2 was similar to that for geometry 1
and therefore have not been included here.
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Figure 35. (a) Platelet deposition at the inlet just before first strut for Wall stent; location
D is proximal to strut in the flow field; location E is distal to strut in the flow field; (b)
normalized average platelet deposition at the inlet just before first strut for time zones 1
and 2; (c) streamlines observed from the side (at maximum flow rate) directed away from
the wall first and then directed towards the gap between the wall and the strut in flow
field, causing low platelet deposition in location A; (d) change in direction of streamlines
close to the strut on the wall. Location B is just upstream of location A and has increased
platelet deposition due to adhesion of platelets proximal to strut in flow field.
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Figure 36. (a) Platelet deposition taken between struts for Wall stent; two geometries
within the same stent type is shown; (b) normalized average platelet deposition between
struts in the direction of flow at time zones 2 and 3. Location C (along flow direction)
had maximum deposition distal to strut due to streamlines directed towards the wall.
Deposition decreased linearly from location C to B as the streamlines get parallel to the
wall in (d); (c) normalized average platelet deposition between struts perpendicular to the
direction of flow at time zones 2 and 3; (d) streamlines (at maximum flow rate) between
struts; note change in direction of streamlines as they approach the struts. Locations A
and D (along flow direction) and location C (perpendicular to flow direction) are close to
the intersection of the struts and have low deposition due to streamlines directed away
from wall.
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Platelet deposition at the outlet to last strut was 88% higher (location B) distal to
the strut compared to regions close to the strut (location C) as seen in Figure 37. Further
distal to the strut, platelet deposition decreases linearly (location A) by 43% compared to
location B. Platelet deposition curve at time=10-20min corresponds to data taken at
location D (shown in Figure 37a); while the deposition at time>20min corresponds to
data taken at location E. In both cases however, the deposition peaks at a point just distal
to the intersecting struts. Streamlines distal to the struts at the outlet are shown in Figure
37c; note that the fluid that flows between the wall and the strut reattaches to the
mainstream flow distal to the strut.
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Figure 37. (a) Platelet deposition at the outlet just after the last strut for Wall stent; (b)
normalized average platelet deposition at time zones 1 and 2; deposition pattern at time
zone 2 were mainly from region D in (a); deposition pattern at time zone 3 were mainly
from region E in (a); (c) streamlines (at maximum flow rate) distal to the last strut.
Location C is close to the strut and has low platelet deposition because of the streamlines
directed away from the wall. Location B has higher platelet deposition because of
streamlines directed towards the wall. Deposition decreases linearly from location B to
location A further downstream of the strut.
Bx Velocity Stent: Comparison of platelet deposition (after 20 minutes of
experimental run) at the concave and convex ends (locations E and D respectively) just
before the first strut is shown in Figure 38a. The platelet deposition at location B was
higher by 39% compared to the region of no flow disturbance (location C) and higher by
61% compared to regions close to the strut (location A). This peak in platelet deposition
was located just proximal to the strut in Figure 38b and little distance away from
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proximal portion in Figure 38c. In Figure 38c, the platelet deposition at location B was
higher by 31% compared to the region of no flow disturbance (location C) and higher by
72% compared to regions close to the strut (location A). Figure 38d shows no
recirculation region proximal to the convex end of the strut. Figure 38e shows region of
recirculation and flow separation proximal to the strut.
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Figure 38. (a) Platelet deposition at the inlet just before first strut for Bx Velocity stent;
(b) normalized average platelet deposition in region D shown in (a). Location B in (b) has
higher deposition and is located very close to the strut because of streamlines carrying
platelets to deposit near the convex end of the strut; (c) normalized average platelet
deposition in region E shown in (a); (d) streamlines (at maximum flow rate) at the convex
end of the first strut; (e) streamlines (at maximum flow rate) at the concave end of the last
strut. Location B in (c), just proximal to the flow separation point in (e) has higher
deposition compared to location A (region of recirculation); flow separation results in
streamlines directing platelets away from the wall. Location C in both cases is in the
region of no flow disturbance.
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In the region between the struts, the platelet deposition peaked just distal to the
proximal strut (location C in Figure 39a) by 87% compared to a point downstream of the
proximal strut (location B). This decrease was linear until some point between the struts
after which it stabilized (line from location B to A). Regions very close to the strut have
low platelet deposition (locations D or A) and location D was 52% lower than the
location C. Figure 39b shows streamlines diverging distal to the proximal strut (top
view); they start to appear parallel to the wall further downstream. Figure 39c shows
streamlines within the region of recirculation and flow reattachment distal to the proximal
strut; there is a region of recirculation and flow separation proximal to the distal strut as
shown in Figure 39d. Similar to the diverging aspect of the streamlines distal to the
proximal strut, the streamlines start to converge proximal to the distal strut.
Platelet deposition within the center connector region (locations C in Figure 4Gb)
was higher by 24% compared to the side connector regions (locations B or E, note
location C was not statistically significant from location E) and by 20% compared to the
proximal portion of the proximal strut (location F). Deposition at C was higher than D by
only 8%, but was not significantly different. Deposition at C was higher than E by 18%,
but was not significantly different. The struts in the graph in Figure 4Gb corresponds to
locations F and G of Figure 40a. Streamlines in figure 40d shows the regions of
recirculation within each of the connector regions; figure 40c shows streamlines from the
main flow that formed these recirculation regions.
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Figure 39. (a) Platelet deposition between struts for Bx Velocity stent; (b) top view of
streamlines (at maximum flow rate) distal to the proximal strut; streamlines tend to
diverge distal to the strut; (c) side view of streamlines distal to the proximal strut.
Location C has higher platelet deposition because the streamlines with activated platelets
are directed towards the wall distal to the strut. Deposition decreases linearly from C to B
as the streamlines orient more parallel to the wall; (d) side view of streamlines (at
maximum flow rate) proximal to the distal strut; streamlines tend to converge proximal to
the strut. Locations A and D correspond to recirculation regions proximal and distal to
strut respectively and have low platelet deposition due to the region being well-separated
from mainstream flow as shown in (c) and (d).
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Figure 40. (a) Platelet deposition at the connector for Bx Velocity stent; (b) normalized
average platelet intensity between the struts in the connector region; the two struts shown
in (b) correspond to the struts at locations F and G in (a); (c) top view of streamlines (at
maximum flow rate) in the connector region; (d) side view of streamlines (at maximum
flow rate) in the connector region. Locations B, C, D, and E are recirculating regions but
of a spiral nature. Locations C and D have higher deposition due to struts being wider and
thus allows for streamlines with activated platelets from the mainstream. Locations B and
E allows for mixing of platelets from the mainstream, but their deposition may differ
based on the platelet residence time dependent on the number of spirals made in that
region.
93
Deposition distal to the convex end of the last strut was greater by 81% compared
to further downstream (location A) and by 122% compared to regions close to the strut
(location C), shown in Figure 41b. Deposition distal to the concave end of the last strut
was greater by 90% compared to further downstream (location A) and by 90% compared
to regions close to the strut (location C), shown in Figure 41a. Deposition distal to the
convex strut further downstream seems to be decreasing linearly while the deposition
distal to the concave strut further downstream seems to be decreasing exponentially.
Figure 41c shows streamlines converging at a point and no region of recirculation distal
to the convex end of the last strut, while distal to the concave end of the last strut, there is
a region of recirculation and flow reattachment region (Figure 41d).
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Figure 41. (a) Normalized average platelet intensity at the outlet to concave end of the
last strut for Bx Velocity stent; (b) normalized average platelet intensity at the outlet to
convex end of the last strut. Location B distal to the last strut has higher deposition
compared to location C close to the strut; (c) streamlines (at maximum flow rate) at the
concave end of the strut; location B is the point of higher deposition where the
streamlines from either ends of the strut meet, as shown in the figure; (d) streamlines (at
maximum flow rate) at the convex end of the strut; location B has higher platelet
deposition due to streamlines directed towards the wall in the region of reattachment.
Location C in both cases has lower platelet deposition. Location A corresponds to a
region further downstream of the strut where the deposition is lower due to streamlines
directed more parallel to the wall.
Aurora Stent: In the region between the struts, the platelet deposition peaked just
distal to the proximal strut (location D in Figure 42a) by 38% compared to a point
downstream of the proximal strut (location B). This decrease was linear and slow
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between the struts (line from location D to A). Regions C, D, and E were not significantly
different from each other, but location D had 5% greater deposition than locations C or E.
Location B was not significantly different from location C, but was lower by 23%.
Regions very close to the strut have low platelet deposition (locations F or A).
Streamlines for this model between struts were similar to Figures 39c and 39d and hence
were not shown. Streamlines diverge distal to the proximal strut; they start to appear
parallel to the wall further downstream. There are regions of recirculation and flow
separation or reattachment, proximal (or distal) to the distal (or proximal strut). Similar to
the diverging aspect of the streamlines distal to the proximal strut, the streamlines start to
converge proximal to the distal strut.
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Very low platelet deposition around areas of the connector (locations A and B) in
Figure 43a were seen. Fully separated regions of recirculation exist near the connectors,
as shown in Figure 43b. Platelet deposition considerably increases (location A) in Figure
44a. Streamlines show spirally recirculating region between the two struts (Figure 44b).
Reattachment point
Separation point
(a)
IA
(b)
Figure 43. (a) Platelet deposition at the connector for Aurora stent; (b) streamlines (at
maximum flow rate) in region B showing recirculation zones. Region A and B have low
deposition because they are well-separated from the mainstream and do not allow mixing
with fresh platelets.
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Figure 44. (a) Platelet deposition at the no-connector region for Aurora stent; (b)
streamlines (at maximum flow rate) showing spirally recirculating regions. Region A is
spirally recirculating with platelets coming in from flow in both directions and therefore
has higher deposition than a location upstream of the proximal strut.
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NIR Stent: Platelet deposition at the inlet to the convex end of the first strut and
the outlet to the concave end of the last strut seems to be the same as the region of no
flow disturbance (Figure 45a and 45b). At about 1mm from the strut, the platelet
deposition is higher at the outlet (location A of Figure 45b) compared to that at the inlet
(location B of Figure 45a). Streamlines show existence of large recirculation regions at
the inlet and outlet to stent (locations D and E respectively in Figure 46b).
Platelet deposition between the first and the second struts of the NIR stent had
soRewhat uniform deposition as shown in Figure 46a. Platelet deposition was 35% lower
at regions close to the strut (locations A and D) compared to a region at the center
(location B or C). Streamlines show that there is a region of reattachment between the
first two struts (Figure 46b). Location B or C may be present in the vicinity of the
reattachment point.
Platelet deposition between another set of struts away from the inlet showed
deposition pattern ye similar to Fig. 39b. The deposition peked just distal to the strut
and decreased linearly further downstream. Deposition was lower at points close to the
struts. Since the deposition pattern was similar, this plot was not shown here.
Platelet deposition within the connector region (location B in Figure 47b) was
21% higher than a region proximal to the proximal strut (location D). The two struts
correspond to locations D and E as shown in Figure 47a. Deposition is low around the
edges of the connector (Figure 47a). Figure 47c shows streamlines in a spirally
recirculating region within the connector zone.
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Figure 46. (a) Normalized average platelet deposition between the first two struts for
NIR stent; (b) streamlines (at steady flow with mean shear stress of 10 dynes/cm2)
showing large recirculation region at the inlet. Location B is the reattachment point,
where the deposition seems to be low; deposition decreases linearly from B to A and
from B to C, as the streamlines get more parallel to the wall.
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Figure 47. (a) Platelet deposition at the connector region for NIR stent; (b) normalized
average platelet deposition at the connector; the two struts correspond to struts in regions
D and E of (a); (c) Streamlines (at maximum flow rate) near the connector for NIR stent.
Location B has higher deposition compared to C because of the spiral recirculation zones
that entrain more platelets from the mainstream. Location A is distal to the strut where
platelet deposition was higher due to streamlines directed towards the wall.
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4 DISCUSSION
The purpose of this research was to measure the platelet deposition between stent
struts under highly resolved conditions in order to directly relate this deposition pattern to
flow dynamics and stent design. Flow patterns are dependent on stent design (Berry JL et
al., 2000; Henry FS, 2000; LaDisa JF Jr. et al., 2004, 2005). Stent design affects
restenosis rates (Kastrati AJ et al., 2001). Hence, flow patterns were expected to affect
restenosis rates. The first vascular response to stenting is formation ofthrombus (Garasic
JM et al., 2000). This process is initiated by the blood platelets. Therefore platelet
adhesion, activation, and aggregation become the foremost processes that occur in
restenosis.
We postulated that instantaneous streamlines could be used as a tool to depict flow
dynamics within the stented region. We postulated that deposition occurs through the
convection of platelets as depicted by these instantaneous streamlines. We first
experimented two-dimensional (2D) idealizations of three-dimensional (3D) stents,
characterizing them in terms of the ratio of the distance between the strut centers to the
strut height. We used three different strut spacings in this case. For 3D stents, four
different models of currently marketed stents were used: Bx Velocity stent, Wall stent,
Aurora stent, and NIR stent. This chapter first discusses the results separately from the
two-dimensional and three-dimensional studies performed previously, for clear
understanding and to avoid confusion. Another part of the discussion also includes 3D
parametric computational models. Later on, we can see how some aspects of this research
could be applied to the experimental 3D stent work. Then we would have a general
discussion of some important aspects of this research based on the 2D and 3D stent
results obtained.
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4.1 2D Experimental Stented Models
The initial thrombotic reaction to the placement of a stent into a diseased artery is a
determining factor for subsequent reestablishment of the endothelium. Thus, a better
understanding of the dynamics of platelet adhesion to stents under realistic flow
conditions can serve to improve stent design and thus eventual clinical outcomes. In our
previous study, platelet deposition on the wall in a 2D stented region was shown to vary
significantly with different stent strut spacings (Robaina S et al., 2003). The stent model
with the closest spacing (L/H=2.5) produced the lowest amount of platelet deposition
both between stents and on the struts as compared to the intermediate (L/H=4.0) and
widest spacing (L/H=O7.) models. However, the method used to trace platelets,
radioactive labeling, did not provide us with direct observation of the attachment of
platelets between the struts, or the spatial distribution of platelets between the struts.
Primarily three main mechanisms influence the adhesion of platelets to the wall:
(1) platelet transport to the wall (by convection, diffusion, or other means), (2) platelet
reactivity with the wall (preceded by platelet activation), and (3) ability to (or lack of
ability to) wash the platelet deposits off from the wall (typically via fluid drag). The
recirculating flow system utilized in this study, along with the peristaltic pump, make it
very likely that platelets are activated and at least moderately reactive with the surface
(due to its hydrophilic nature), particularly in the vicinity of the stent. Also, for the
geometries considered in this study, recirculation dominates the near wall flow in the
stented region, creating large regions of low shear, so washout of platelet aggregates
should be relatively low. Therefore, we postulate that the medium through which
activated platelets get attached to the wall are the instantaneous streamlines that depict
the fluid flow pattern; thus the platelet flow and hence attachment is convection driven.
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In all of the stent strut spacing designs utilized for this study, the adhesion of
activated platelets was found to coincide with patterns of convective delivery of those
platelets to (or from) the wall, rather than the wall shear stress pattern. This is in direct
agreement with the findings of Longest PW and Kleinstreuer C, 2003. As indicated in
Figure 48, platelet deposition is always higher in areas where there are streamlines with
components perpendicular to the wall and flow is directed towards the wall (upstream
and downstream of separation and reattachment points, and in the center of recirculation
regions) than in areas where streamlines are parallel (with no curvature, as in fully
developed flow regions and downstream of the proximal recirculation region in the
largest strut spacing) to the surface. Conversely, in areas where a component of the
streamline is perpendicular to the wall but flow is directed away from the wall (separation
and reattachment points, and corner regions of the struts), the platelet deposition is
always lower than in areas where streamlines are parallel to the wall. This study may hint
that flow patterns may play a larger role in restenosis than the wall shear stress.
Recirculation regions allow entrapment of procoagulant agents (with refreshment
occurring by entrainment from the main flow during flow pulsatility) and a convergence
of streamlines that bring those agents close enough to the wall to react. At the inlet to the
first strut, platelet deposition at the region of recirculation (see Fig. 17a, location B) was
significantly higher than the region of no flow disturbance (location D). The
instantaneous streamlines at the region of no flow disturbance were parallel to the wall
(see Fig. 1 7b); hence only those activated platelets that were carried by instantaneous
stre lines very close to the wall got depsited. However in the region of recirculation,
the recirculating instantaneous stre lines (which carry platelets with partial mixing
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from the mainstream flow) strike the wall surface with activated platelets in increasing
numbers as the center of the recirculation is approached.
T eiof FlowRe ime Direction of Streamlines Platelet Deposition
Upstreamr of Stent Parallel to wall Defined by di sion
through streamlines in
contact with the wall
Recirculation -- Distal to strut alone
a"
Recirculation --- Proximal to strut ".. Directed towards the wall Greater
deposition
Reattachrent Point
Separation Point ... - Directed away from the wall Less
deposition
Corner Flow Region
Figure 48. Figure summarizes average platelet deposition based on the flow regime
under consideration and the direction of flow of streamlines.
Another reason would be that the region of recirculation varies in size within the
flow cycle; hence platelets get deposited not just at the center but also at points around
the center of the recirculating region. This is true for the smallest strut spacing also where
platelet deposition is significantly higher around the center, since the smallest strut
spacing corresponds to constantly recirculating flow (see Fig. 19a). From Fig. 19b, we
can see that the instantaneous streamlines recirculate such that the momentum will cause
platelets to strike the wall surface in increasing numbers toward the center. Then the
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stre ines start to separate off the wall to complete recirculation, thereby carrying
platelets with them away from the wall. This deposition pattem is similarly explained in
the region of recirculation proximal and distal to the strut (locations B and H
respectively) for the largest strut spacing case (see Fig. 20a).
Regions of recirculation distal to the struts generally showed significantly higher
deposition compared to regions proximal to the struts. This is best illustrated in the
largest strut spacing case (Fig. 20). At the proximal end of the downstream strut, the
instantaneous streamlines of the mainstream flow separate from the wall and traverse
away from the wall (see Fig. 20b, location C), hence the number of platelets that gets
mixed within the region of recirculation from the mainstream flow is less; therefore the
platelet deposition is lower. However, at the distal end of the upstream strut, the
instantaneous streamlines of the mainstream flow traverse towards the wall and strike the
wall, thus carrying more activated platelets to be deposited distally (location F); therefore
the platelet deposition is higher. The platelet deposition at the inlet to first strut and the
outlet to last strut could not be compared because of the time difference in images taken
at these regions; however the average normalized platelet deposition curves plotted
shows that platelet deposition is higher at the outlet to last strut (see Fig. 18a, Fig. 22a).
Since the platelets in the system are already in an activated state, these changes in platelet
deposition upstream and downstream of the stent are mostly due to convective transport
of activated platelets, rather than their activation in a vortex followed by their escape
from that vortex to be deposited downstream. The deposition of activated platelets further
downstream away from the stent region is beyond the scope of this study.
At the comer regions very close to the strut (proximal or distal to the strut), the
platelet deposition was significantly lower when compared to other regions between the
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struts. This may be due to two main reasons, and can be gleaned from fig. 19b: (1) the
number of instantaneous streamlines closer to the struts on the wall reduces and (2) the
instantaneous streamlines closer to the struts on the wall seem to transport the platelets
away from the wall in that region (see Fig. 18b, locations A and C). This region of
stagnant flow closer to the strut with significantly very low platelet deposition (when
compared to other regions) is found in all stent strut spacing cases.
The point of separation (or reattachment) separates the region of recirculation
from the mainstream flow. Platelet deposition was consistently lower in this region
compared to just upstream or downstream of these locations. The platelet deposition in
the reattachment point (see Fig. 20a, location G) is significantly lower than that in the
nearby recirculation region (location H) or just downstream of the reattachment point
(location F) because the instantaneous streamlines at this point of reattachment near the
wall diverge from one another, and thus platelets and procoagulant agents are not carried
to these locations (see Fig. 20b, location G). Similarly, the platelet deposition in the
separation point (see Fig. 20a, location C) is significantly lower than that in the nearby
recirculation region (location B) or just upstream of the separation point (location D). The
instantaneous streamlines at the separation point near the wall traverse towards each other
from either ends and then traverse away from the wall sharply, thus carrying platelets and
procoagulant agents away from the wall at this location (see Fig. 20b, location C).
However, there is still some platelet deposition shown in these points of separation or
reattachment in the normalized deposition data (see Fig. 18a, Fig. 20a, Fig. 22a). There
are two main reasons; (1) the point of reattachment moves slightly due to flow pulsatility;
and (2) as time increases, the platelet aggregates grow to eventually cover up the
reattac ent point, as observed under the microscope; this may be why no statistical
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significance was found in platelet deposition at the point of separation (location C) and
the region of no flow disturbance (location D) at the inlet to first strut (Figure 19). The
point of reattachment distal to the strut showed significantly higher platelet deposition
compared to the deposition at the point of separation proximal to the strut (see Fig. 20a,
locations G and C respectively). This is similar to the pattern of platelet deposition
observed previously between the recirculation regions distal and proximal to the strut (see
paragraph 3 of Discussion section). This is because the instantaneous streamlines of the
mainstream flow distal to the strut traverse towards the wall and strike the wall, hence
there is more deposition distally (see Fig. 20b, locations between E & F, F, E); however
the instantaneous streamlines of the mainstream flow proximal to the strut separate from
the wall and traverse away from the wall, hence there is less deposition proximally
(locations B, C).
Platelet deposition decreases almost linearly from the point of reattachment to the
point of separation in the largest strut spacing (from locations little downstream of F to C
in fig. 20a). This decrease in platelet deposition is likely due to the decrease in platelet
availability near the wall as platelets are deposited. Very little mixing occurs in this
region (compared to the recirculation regions), so depletion of available platelets occurs
in the flow confined to very near the wall.
The platelet deposition pattern between struts in the intermediate strut spacing has
the least spatial variation of the three configurations (Figure 22). The platelet deposition
pattern can be thought of as a combination between the deposition patterns in the smallest
and largest strut spacing. Distal to the upstream strut, the platelet deposition was
significantly higher than at the center (see Fig. 21a, locations D and C respectively). It
could be postulated that this may be because (1) during the time points in the flow cycle
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when the fluid reattaches to the wall between struts, the distal end of the strut would have
more platelet deposition due to instantaneous streamlines striking the wall at an angle
with activated platelets (see Fig. 21b, location C and D); (2) during the time points in the
flow cycle when the fluid recirculates between struts, the two recirculation regions try to
combine partially into a single flow stagnation zone with two slowly turning vortical
structures (see Fig. 21c, locations B, C and D); there are no longer any individual
separation or reattachment points, however, the platelet deposition pattem may be still
similar to that seen above in (1); and (3) in the intermediate strut spacing, the flow
remains totally recirculated only 40% of the time, while it remains reattached 60% of the
Stime. If we combine (1), (2), and (3), the result is a platelet deposition pattem as seen in
Fig. 22a. The probability of platelet attachment may increase because cells experience the
varying flow patterns of one cycle. The reattached fluid entrains more activated platelets,
while the slowly turning vortices trap them, increasing the time available for interaction
with the wall.
For the intermediate strut spacing, the platelet deposition between struts increased
in time zone 3 relative to time zones 1 and 2. It is to be noted that the analysis included
normalization of data between struts from each time point with the inlet (or upstream to
stent or region of no flow disturbance) data at roughly the same time point. Since we are
mostly interested in platelet deposition at later time points, it was interesting to note
significance between the latter two time zones (time zones 2 and 3). Also shown in the
normalized platelet deposition data (Fig. 21 a), the data at each time zone did not follow
the same patt ; hence it could be concluded that the platelet dposition in regions
between struts of the intermediate strut spacing was increasing in time, faster than at the
inlet (or upstream to stent) region.
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Platelet deposition patterns were compared to the instantaneous streamlines at
minimum flow for almost all models except the intermediate strut spacing. The
instantaneous streamlines at maximum flow looked the same as that at minimum flow for
these models; this is because the flow pattern is similar throughout the flow cycle for
these models. What is actually varying is the point of separation and reattachment if any,
during the flow cycle. In the intermediate strut spacing model however, platelet
deposition curves were compared to instantaneous streamlines at minimum flow and
maximum flow; these instantaneous streamlines represent the two extreme flow patterns
that this strut configuration was subjected to, during the flow cycle.
The intermediate strut spacing corresponded to highest platelet deposition in our
previous study (Robaina S et al, 2003). The observation in this study that platelet
deposition is still increasing between the intermediate struts, compared with upstream,
may confirm this previous observation.
4.2 Generic 3D Parametric Stented Models
Flow characteristics of four different stent strut designs were studied using 3D
computational fluid dynamics, concentrating specifically on three strut design parameters
- strut interspacing (h), spacing between concave to convex portion of the same strut (f,
or "amplitude"), and radius of curvature of the strut (r). Four specific strut geometries
were considered (see Fig. 12) under high (1 0 5 dynes/cm2) and low (2 10 dynes/cm2 )
shear stress flow conditions. The aim was to understand how stent design affects flow
patterns, with an eventual aim to improve stent design to minimize restenosis.
Models without the axial connectors seem to have more benefit from the fluid
dynamic point of view compared to models with the axial connectors. It is assumed that a
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greater degree of restoration of the normal, physiologic WSS is beneficial to the artery
wall. The percentage restoration in axial WSS in the models without connector was as
much as 11% larger than their counterpart models with connector, for all strut geometries
studied (see Fig. 29). The connector divided the symmetric central shear stress region and
the shear stress itself was low in the region surrounding the connector. The separation
parameter was <0.1 around the connector, indicating fluid reattachment for >90% of flow
cycle. However, area exposed to the separation parameter <0.1 was greater for models
without connector compared to those of models with connector. The area exposed to
separation parameter >0.5 was less for models without connector under both high and
low flows (see Fig. 31). The effect of connectors on the transverse WSS could be
considered relatively insignificant under both flow conditions (see Fig. 30). Reducing
strut-strut connectors by 29% reduced thrombosis by 69%, and neointimal hyperplasia by
38% (Rogers C et al., 1995). Connectors between struts provide mechanical integrity to
stent design and hence cannot be totally neglected; however, they should be used only
when required and in parallel to the main flow.
The strut geometry with the largest interstrut spacing (h=3.6mm) seems to be
comparatively more beneficial to the artery from its fluid dynamics (see Fig, 29). The
mean axial WSS restoration between the struts was the greatest for the stent geometry (c)
(67% of the nominal value for the model with connector, 76% for the model without
connector). The general tendency in increase in percentage restoration of the average
mean axial shear stress between the struts by 42% was observed when the strut parameter
h was increased from 1.8mm to 3.6m Thus, with larger strut spacing, greater
percentage of restoration of shear stress was observed. No significant restoration in WSS
was seen when f was increased from 0.9mm to 1.8mm (accompanied by increase in r
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from 0.45mm to 0.9mm); however decreased restoration in shear stress was observed
when the strut parameter f was increased from 1.8mm to 3.6mm. There existed a narrow
band with low mean axial shear stress between struts with increase in strut parameter f;
this band divided the shear stress region, hence lesser percentage restoration in shear
stress was observed. For high flow, when strut parameter f was increased from 1.8mm to
3.6mm, the axial shear stress restored was decreased by 16%; however when f was
increased from 0.9nm to 1.8mm (accompanied by increase in r from 0.45mm to 0.9mm),
the axial shear stress restored was decreased only by 4%. This decreased restoration in
axial shear stress is probably due to the combined effect of r and f This was due to larger
interstrut spacing that allowed for increased WSS restoration. Also, the struts were less
perpendicular to the flow; hence the transverse shear stress was lower. Regions of
recirculation for at least 50% of flow cycle (typified by separation parameters of >0.5)
and regions of flow reattachment for most part of the flow cycle (typified by separation
parameter 0.1-0.5) were also relatively low for this model under both high and low flows
(see Fig. 31, 32). When the strut amplitude f was increased from 1.8mm to 3.6mm, the
segments connecting the arcs of the same strut were more parallel to the flow; hence the
shear stress and flow separation parameters studied for stent model (d) were close to that
of the stent model (c). However, this strut geometry created a narrow bad between the
struts which causes a sharp local flow disturbance and because of the narrow band, there
was a 16% decrease in mean axial WSS restoration. While the effects of such sharp local
flow disturbances on intimal hyperplasia are unknown, it is presumably desirable to
restore the WSS as much as possible. Thus, strut geometries should be based on
increased interstrut spacing and lower intrastrut concave-to-convex arc spacing (i.e. strut
geometry corresponding to stent model (c) may provide more benefits).
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It is difficult to separate the effect of strut parameter f and r on shear stress and
flow separation. The strut parameters f and r define the strut geometry to a large extent,
hence the combined effect of both is significant. Increasing r and f reduced restoration of
axial shear stress between the struts, and increased the transverse WSS, which was
indicative of eater flow disturbance. Increasing r and f increased the area of flow
recirculation for most part of the flow cycle characterized by separation parameter >0.5;
however increasing f with same r did not cause any tremendous change in separation
parameters. In all cases studied here, flow separation regions were concentrated near the
proximal and distal portion of the apex and base of the strut. The circumferential pitch W
of the flow chamber was kept constant while only the strut parameters f, and r were
varied; if this dist ce is varied, the same strut parameters used for the simulations will
produce different geometries; one could then deduce the effect on shear stress and flow
separation from the cases studied.
An interesting observation from the contour plots showed that large mean axial
shear stress occurred proximal to the distal strut (0.66mm, 0.42mm proximal to the
second strut for high flow, low flow respectively); this means the regions of low WSS
and hence the regions of recirculation, if any, are larger distal to the strut. This finding is
consistent with other studies of stented artery flow patte (Berry JL et al., 2000; LaDisa
JF Jr. et al., 2003). The presence of stents creates regions of flow recirculation. In regions
of complex flow, the relationships between flow and thrombosis are not very clear.
Convection patterns and residence time may modulate platelet deposition in separated
flows (Wootton DM et aL., 1999). Platelets are carried by the streamlines and more
number of streamlines strike the arterial surface distal to the strut, hence potentially
triggering eater deposition at those regions. The higher residence time in the
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recirculation regions may favor platelet deposition (Karino T and Goldsmith HL, 1979).
Therefore, platelet deposition may be higher distal to the struts. For the low flow the
percentage restoration of mean axial shear stress between struts was lower than that for
the high flow by 10-12% (see Fig. 29). Hence there seems to be more number of regions
with relatively lower mean WSS under low flow conditions. Since higher WSS have been
associated with reduced neointimal hyperplasia, the low flow condition seems to pose a
higher potential threat towards restenosis (Hof R et aL., 1997, 1998; Clier SG et
aL, 2003). Regions of reattachment for most part of the flow cycle governed by
separation parameter 0.1-0.5 were 82-90% higher under low flow compared to high flow
condition; those regions may be sites of higher platelet deposition (Robaina S et aL,
2003).
The largest mean transverse shear stresses were 30-50% of the largest mean axial
shear stresses. The large mean transverse shear stresses between the struts occurred in the
regions where the mean axial shear stresses were low. From the fluid dynamic point of
view, the transverse shea stress indicates a directional change in the fluid flow; this is
evident from the streamlines. Platelets are sensitive to shear rates. Therefore, the resultant
shear stress may have an effect on platelet adhesion. The study into the platelet
deposition with high spatial resolution using these stent models may reveal the effects of
the altered flow on platelet deposition.
The implications of shear stress on the reaction of the artery wall are not limited
to platelet deposition. Endothelial cells responded differently to differing WSS applied in
differing directions through mechanotransduction and by altering gene expression
(Brooks AR et al. 2002). Most notably, the expression of infa mato cell adhesion
molecules such as ICAM-1, VCAM-1 and E-selectin increases with exposure to low
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shear stress (Sampath R et al., 1995). It is clear that an effort to increase WSS after stent
implantation would likely be beneficial. It should be noted that the procedure of stent
implantation results in denudation of the endothelium, yet it has been shown that remnant
endothelial patches remain between the struts (Rogers C et al., 1999). Presumably, these
patches of endothelial cells, along with those that migrate or proliferate into the denuded
areas, will fare better in the presence of shear stress.
The comparison of the flow characteristics between different strut configurations
did not change under high or low flow conditions (Fig. 29, 30, 31, 32), however the
figures give a nice visual and quantitative description of variations in WSS and
separation parameter of a single strut configuration under hgh and low flow conditions.
For example, all strut design models had descending normalized mean axial WSS for
high flow, which followed the same order under low flow (Fig. 29). Therefore, the effects
of strut configuration on flow characteristics were basically the same under the high and
low flow utilized in the study. However, Fig. 29 also revealed that the percentage
restoration in axial shear stress was lower for the low flow by 10-12%. This indicates that
regions of already low shear stress will be more easily affected by the stent geometry.
The numerical results are coherent with the experimental results using a square
lumen as the stented artery model (Benard N et al., 2003). Three weak WSS regions were
identified through particle image velocimetry method. These regions correspond to the
proximal and distal regions of the base defined in fig. 12, where flow recirculation
occurs. Our simulation results can also give more information about the "critical
shearing" zone identified in the experiment owing to the much better spatial resolution of
numerical simulations. WSS is restored to a large extent in this zone because of the large
inter-strut spacing.
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The height of the stent strut is a little higher than those used in the clinical trials
(Kastrati AJ et aL, 2001). The higher strut may increase the flow disturbance around the
strut from the fluid dynamics point of view. The same height was used for all the models
in the study. The trends and the comparative results obtained should not be greatly
affected by small differences in height.
The mechanical interaction of the stent and the artery wall should also be
considered while optimizing stent design. This study focused on the fluid dynamics of
stented arteries. The larger inter-strut spacing would allow greater extent of flow
restoration. The stents would be weaker in this case because the thickness of the strut is
limited too. The vascular tissue may prolapse between struts if the inter-strut spacing is
too large. The establishment of an optimal inter-strut spacing would involve
consideration of both fluid dynamics and the solid mechanics of stent/artery interaction.
Arteries are always being subjected to pulsatile flow in vivo. One of the strengths
of this study was the inclusion of pulsatile flow, which had an important influence on the
WSS. Figure 13a and 13b show the axial WSS oscillating as a function of time. All time
points in the flow cycle can be detected using the time point t1 as a reference in figures
13a or 13b. At time points in the flow cycle with the same velocity but where flow
accelerates (i.e. 50' time point) and flow decelerates (i.e. 1 0 0th time point), the
instantaneous axial WSS between the two time points varied by ~28% and the
instantaneous transverse WSS varied by 23% for the high flow condition. The
percentage change in the instant eous WSS were higher for the low flow condition. The
instantaneous WSS also changed around the time point of minimum flow (i.e. 2 0th ad
30t time points) and around the time point of peak flow (i.e. 70t and 8 0 th time points);
note that the paired time points (as above) have the same value of velocity. Such changes
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in WSS indicate the importance of accounting for pulsatility in analyzing flow in stented
arteries.
The present results should be interpreted within the constraints of potential
limitations. Accuracy from CFD results depends on computational domain and
computational mesh size. The computational domain in the cross-stream direction was
flat, rather than curved, since the height of the stent strut is 8% of a 1.8 mm arterial
radius. Furthermore, the lumen of the stented artery may have a polygonal shape with
each strut serving as a vertex immediate after stenting (Garasic JM et aL., 2000). The aim
of these simulations was to predict the near-wall flow disturbances of stented arteries and
hence the computational domain is justified. There exists prolapse of vascular tissues
between struts after stenting. No prolapse was considered in this study. The level of
prolapse has been demonstrated to depend on stent design (Prendergast PJ et al, 2003). A
large degree of prolapse might have an effect on the flow patterns. Small intimal flaps
protruding between stent struts would certainly have a significant effect on the flow
patterns demonstrated here. With regard to artery wall motion due to cycling pressure, it
is important to note that stents distend the artery wall to a non-physiologic degree, so the
artery wall is already highly stretched. This fact, coupled with the relatively close strut
spacing, means that the artery wall probably does not undergo large enough deformation
over the cardiac cycle to influence the flow patterns. This was confirmed previously in
2D (Henry FS, 2000). Our computational models were shown to be mesh independent
based on convergence (<4.6%) of WSS values. Time step independence was also
determined from convergence (<5%) of the mean axial WSS values. Increasing mesh size
or the number of time points within a flow cycle may have improved our results slightly,
but would take an enormous amount of time. Moreover, the convergence in our results is
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within acceptable limits along with the rigid wall assumption (LaDisa JF Jr. et al., 2003;
Myers JG et al., 2001; Back M et al., 1994). The stent-to artery diameter ratio in the
stented section should be larger than one in order for stents to scaffold against the
diseased arteries. The use of a larger (1.2: 1) deployment ratio has been shown to increase
exposure to low WSS by 12-fold compared with stents implanted in a 1.1:1 stent-to-
vessel ratio (LaDisa JF Jr. et al., 2004). The present study did not consider the effects of
stent-to-artery ratio. The assumption that blood is a Newtonian fluid, while generally
valid in the medium to large size arteries that are typically stented, may affect the flow
patterns in the low shear regions near the stent struts. Nevertheless, the flow
characteristics demonstrated in this 3D unsteady flow study would be expected to be
indicative of the in vivo flow patterns to the extent that they are used to compare different
stent designs.
In conclusion, from the hemodynamic point of view, guidance for stent design
optimization could be obtained from the results of this study. The longitudinal distance
between adjacent rows of struts should be larger in order to maximize WSS.
Additionally, the struts should be wherever possible oriented parallel to the vessel axis to
reduce the area of flow recirculation. Longitudinal connectors should be used only as
necessary. Further experimental investigations (both in vitro and in vivo) should be
performed to establish more directly the relationship between these 3D CFD results and
the processes of restenosis.
4.3 311 Experimental Stented Models
In our previous study, localized platelet deposition on the wall in a 2D stented
region was shown to vary significantly with different stent strut spacings (Duraiswamy N
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et al., 2005). Platelet deposition varied at all points within the stent struts; for example,
deposition was very low at the reattachment or separation point; deposition was higher
distal to the strut compared to proximal region of the strut; regions of recirculation distal
to the strut had greater platelet deposition compared to regions of recirculation proximal
to the strut; etc. However, the geometry of the stent was relatively simple, characterized
by only one single design parameter, the ratio of the distance between the centers of two
struts (L) to the strut height (H). Real world stents are however far more complex and a
single design parameter cannot characterize them. The purpose of this study, using
fluorescently labeled platelets, was to measure the platelet deposition between 3D stent
struts in order to directly relate this deposition pattern to flow dynamics and stent design
d their similarities, if any, with 2D stents studies conducted previously.
We postulate again that the medium though which activated platelets get attached
to the wall are the instantaneous streamlines that depict the fluid flow pattern; thus the
platelet flow and hence attachment is convection driven.
In Wall stents, platelet deposition was always lower proximal to the intersection
of two struts (location A in Figure 35b, Figure 36b, 36c) because (1) the mainstream flow
separated from the wall, and (2) the fluid that flows between the wall and the strut in the
flow field tries to separate from the wall with the mainstream flow, but finally makes a
bend to enter this region (Figure 35c, 36d). This results in less convection of activated
platelets to the wall near the intersection of the struts. As indicated in Figure 48, platelet
deposition is always higher in areas where there are streamlines with components
perpendicular to the wall and flow is directed towards the wall (upstream and
downstream of separation and reattachmnent points, ad in the center of recirculation
regions) than in areas where streamlines are parallel (with no curvature, as in fully
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developed flow regions and downstream of the proximal recirculation region) or directed
away from the wall (proximal to a strut). Platelet deposition is also always lower distal to
the intersection of two struts (location D in Figure 36b) because the fluid that flows
between the wall and the strut in the flow field tries to reattach to the mainstreamn flow by
making a bend away from the wall and then curving back towards the wall to join the
mainstream flow (Figure 37c). Note that when the streamlines are directed away from the
wall, the convection of activated platelets to that region is low. Note here that the
streamlines proximal to the strut and distal to the strut, in the region between struts, are
the same as that for the inlet proximal to first strut and the outlet distal to last strut
respectively. Regions proximal to the strut had 65% larger deposition (location B in
Figure 35b) with time compared to region of no flow disturbance; this is due to the
existence of the strut in the flow field. The instantaneous streamlines strike proximal to
the strut and deposit activated platelets on the strut. As time progresses, more platelets get
attached that may form a platelet plug, which may further help in more platelets attaching
to the nearby wall. The formation of such platelets plugs could block the flow through the
gap between the stent in the flow field and the wall in that region, thus changing the flow
dynamics. However, wherever this gap was larger (particularly at the intersection point of
the two struts), there seemed to be always flow between the wall and the stent in the flow
field. The same is true for platelet deposition proximal to the strut, of the region between
struts (geometry 1 or geometry 2 in Figure 36a).
The bend or turn of a streamline is not just directed away proximal to the strut or
towards the wall distal to the strut. Figure 35d shows the streamlines entering the gap
between the wall and the strut in flow field, directed away from the strut on the wall
distally. Thus convection seems to carry platelets away from this strut on the wall. This is
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also another reason why there is very less platelet deposition proximal to the strut on the
wall compared to the strut in the flow field (Figure 35a, Figure 36a). Note that the platelet
deposition in this case was an observation from the images and not any quantitative data.
Platelet deposition (in the direction of mainstream flow) distal to the proximal
strut (location C in Figure 36b, location B in Figure 37b, location C in Figure 39a,
location E in Figure 42a) was higher than further downstream (location B and C and B
and B respectively); this is mainly due to the instantaneous streamlines carrying activated
platelets directed towards the wall, distal to the proximal strut. The decrease from
location C to B in Figure 36b, from location B to A in Figure 42b, from C to B in Figure
39a, and from E to B in Fig. 42a is linear due to the depletion of platelets on the wall as
the streamlines get more parallel to the wall. At time=10-20min in Figure 37b, most of
the data was taken concentrating on location D of Figure 37a; however at time>2Omin,
most of the data concentrated on location E of Figure 37a. At time>2Omin, the decrease
in platelet deposition after location B may be caused by a strut (not visible in Figure 37a)
in the flow field, that may be causing some flow disturbances in that ea leading to the
reduction. However, it is important to note that platelet deposition was always higher at
the outlet to the last strut compared to the inlet to first strut (see Figures 35a, 37a, 38b,
42a). This was similar in all stent types except NIR stent, which will be discussed later.
Width of the struts in the circumferential direction could influence the platelet
deposition greatly. In Figure 42a, the platelet deposition was the maximum at location D,
instead of at location E, as was the case with other stent types. Since the struts were very
closely associated at the proximal end, more streamlines with activated platelets were
directed away from the proximal end and hence, deposition may be higher a little
downstream of the proximal strut. The deposition pattern showed that the decrease in
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platelet deposition with axial distance was linear but slow in Aurora stent compared to
other stent types line Bx Velocity stent (see Fig. 39a also); location D was significantly
higher tha location B in Figure 42a. Since the axial distance was larger in Aurora stent
compared to other stent types, one would think that the platelets would get easily
depleted. One possible explanation could be that (1) before the streamlines start to get
parallel to the wall, the converging region of the next strut begins; the decrease in platelet
deposition we see may be just due to flow separation from the wall in this region rather
than depletion of platelets near the wall; (2) ideally platelets would get together when
flow converges; in the other models like Bx Velocity stent, the platelets have already
depleted when the converging section of the strut begins, so we may be unable to see a
major change in platelet adhesion in this section; however, for Aurora stent, platelets may
get together at the converging section of the strut and thus further slow the rate of platelet
depletion near the wall.
Computationally, there is no significant difference in the fluid flow within
geometry 1 and 2 of Wall stent except the difference in the entry and exit of fluid into or
from geometry (Figure 36d). Platelet deposition in the direction of mainstream flow has
the same pattern of deposition for struts of geometry 1 and geometry 2. Platelet
deposition (perpendicular to the mainstream flow) was higher at the center (location B in
Figure 36c) due to activated platelets attaching as a result of being carried towards the
wall, distal to the proximal strut. However, the regions close to the struts (locations A or
C) could have higher or lower platelet deposition depending on the geometry of the
struts. In geometry 1, fluid enters from the gap between the strut and the wall on the top
and side, hence location C may have slightly higher platelet deposition compared to
location A. In geometry 2, fluid enters from the gap between the strut and the wall at the
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bottom and side, hence location A may have slightly higher platelet deposition compared
to location C.
Platelet deposition curves for two different time zones time=1 0-20mn and
ti e>20min was plotted only for Wall stent to see if time had a significant effect on
deposition. Figures 35-37 show that time did not have a significant difference on platelet
deposition. Hence, for other stent types deposition patterns for time>20min were shown
and statistically analyzed.
All stent types except Wall stent have convex and concave ends of the first strut
subjected to flow. The words convex and concave have been used subjectively. Here,
they are defined based on the orientation of the strut to the mainstream flow. The platelet
deposition patterns can be very different near both ends. Platelet deposition was higher
just proximal (tip) to (ot) the convex end of the first strut (location D in Figure 38a,
location B in Figure 38b) compared to the region of no flow disturbance; the
instantaneous streamlines with activated platelets strike the strut that was obstructing the
flow field and deposits platelets on the strut or nearby the wall (Figure 38d). As the fluid
travels within the stent, towards the concave end, the deposition was lower near the end
of the strut (location A in Figure 38c, also true for Aurora stent); this was due to the small
region of recirculation that is strictly separated d does not receive many platelets from
the mainstream flow (see Figure 38e). The deposition was higher (location B) some
distance away from the proximal end; this region corresponds to the flow separation from
the wall, which means that deposition would not be significantly different from the region
of no flow disturbance (location C). However the deposition closer to the struts (inclined
portions, or connectors of concave and convex ends) was higher, which may have
increased the platelet intensity after processing at location B. Note that for Aurora stent,
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this may not be true as the struts were more inclined in the direction of flow and less
platelet deposition may be seen in a similar zone. However, the above statement cannot
be told for certain at this point since only two experiments were done with Aurora stent.
Analysis of data from more experiments of this type would show if this would really be
the case. This statement is supported by the 3D computational simulations that show the
more parallel the connector between the convex and concave ends of the strut to the
mainstream flow, the less separation near that connector (see Figures 23-28 or see He Y
et al., 2005).
The above observation of deposition being higher at the convex end of the strut
was made only at the inlet just before the first strut and was usually not present in the
region between struts. It may be possible that the platelets interact a foreign object for the
first time at the inlet and hence, there is more deposition at the inlet just before first strut.
As time progresses, more platelets may be getting adhered and activated at the inlet
compared to a similar geometrical location within the stent. As said earlier, more
experiments have to be done to evaluate the effect of platelet deposition near the
connector of convex and concave end of the strut and relate to its inclination to the flow.
For Bx Velocity stent, the distance between the struts was ~3mm (see location B
to A in Figure 39a), this was large enough to allow for deposition to plateau (similar to
the region of no flow disturbance). This plateau in platelet deposition was due to the
depletion of platelets as the streamlines get more parallel to the wall distal to the
proximal strut. This is also expected to be observed at the outlet to the stent for all stent
types.
Regions of recirculation proximal to the strut in 3D stents have very low platelet
deposition (see location A in Figure 39a, location A in Figure 42a). Again, this was
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because of flow separation from the wall proximal to the strut and a tight region of
recirculation that remained fully separated such that too much mixing of platelets from
the mainstream flow did not occur (Figure 39d). The region of recirculation distal to the
strut in 3D stents also has very low platelet deposition (location D in Figure 39a, location
F in Figure 42a). One would have expected at least the recirculation regions distal to the
strut to have more platelet deposition because of flow reattachment distal to the strut that
gets more activated platelets to the wall. This may be again because of a tight region of
recirculation (see Figures 39b and 39c) and the geometry of the strut.
Regions of recirculation near the connector region of two struts (locations A and
B in Figure 43a) of Aurora stent, had very low platelet deposition due to the well-
separated recirculation region (as shown by the streamlines in Figure 43b). The previous
statement is based on purely qualitative data from the experimental images obtained and
from previous observations of low platelet deposition in recirculation regions of other
stent types. Image processing would result in averaging the pixels where the connector
was present between the struts and therefore would not be appropriate for analysis.
Flow reattachment points and flow separation points were not visible in 3D stents,
because of the low (4x) magnification of the lens used for image capture. However, the
reattachment points and separation points were visible in Aurora stent as seen in Figure
43a. Note the platelet deposition was low in these regions as the flow was directed away
from the wall.
Platelet deposition at the outlet, distal to the concave and convex ends of a strut
were different. The pe in platelet deposition close to the concave end of the last strut
(location B of Figure 41a) was caused by a combination of the lack of recirculation
region distal to the strut and the intersection of streamlines from either sides of the strut
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(see Figure 41c). The deposition seemed to be decreasing exponentially further
downstream and this may be due to the lack of a flow separation region distal to the last
strut; streamlines are more parallel to the wall after the intersection point near the
concave end of the last strut and thus platelet deposition may be decreasing
exponentially. The pe in platelet deposition at the convex end of the last strut (location
B of Figure 41b) was located distal to the region of recirculation (see Figure 41d) due to
streamlines carrying activated platelets directed towards the wall; the platelet deposition
decreased linearly further downstream due to the existence of a flow separation region; as
the streamlines further downstream get more parallel to the wall, the platelets get
depleted and hence, the deposition decreases linearly. The above was observed in Bx
Velocity and Aurora stents. As stated earlier, recirculation regions have very low platelet
deposition (location C of Figure 41b).
Each stent type has a different design for a connector between the struts. Platelet
deposition within the connector (location C of Figure 4Gb, location B of Figure 46b) of
Bx Velocity stent was significantly higher than in other locations of the connector (like
locations B or E in Figure 40b) and regions proximal to the first strut (location F of
Figure 4Gb, location C of Figure 46b). This may be because (1) of the existence of a
spirally recirculating region (see Figure 40c and 40d, within location C or D, and see
Figure 46c, within location B) that provides for adequate mixing of platelets from the
mainstream of flow; (2) some locations (like locations C and D of Bx Velocity stent,
location B of Aurora stent) are wider than others (for example, locations B or B of Bx
Velocity stent); and (3) the spiral nature of the flow may help in increasing the residence
time of the platelets on the wall. Note that at location B, the fluid generally does not
undergo more than one complete recirculation (see Figure 40d); this is not the same in
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location E. One could then propose that the decrease in residence time of the platelets in
location B may cause decrease in platelet deposition over time in this region compared to
location E. Thus the spiral nature of the flow tends to deposit more platelets on the wall.
Again, platelet deposition within the region between two non-connecting struts of Aurora
stent (see Figure 44a) was higher than in the region proximal to the first strut; this was
due to the existence of spiral flow between the two struts that allowed entrainment of
more activated platelets from the mainstream flow.
All of the four stent designs studied had connectors between all stent struts.
Previous 3D computational simulations between four different parametric stent design
types showed that the lack of a connector between stent struts increased the percentage of
wall shear stress restoration and decreased the level of flow separation near the wall or
the struts (see Fig. 29, 32 or see He Y et aL, 2005). Hence, one should consider the
advantages of having a connector between the struts at the time of the design. We have
also seen from the images previously that the more complicated the design of the
connector, the more complex the flow mechanics in that region. Hence, one should
consider the advantages of having a certain design criteria for the connector.
In the semi-expanded stents (where the stent-to-artery diameter ratio was less than
or equal to 1.2:1), the outlet distal to last strut had much higher platelet deposition
compared to the inlet proximal to first strut. However, in an over-expanded stent, for
example in NIR stent, the platelet deposition at the inlet and outlet to stent were the same
as that of the region of no flow disturbance (see Figures 45 45b). At the inlet, there is a
large recirculation region, the reattachment point of which exists at a point between the
first and the second struts (see Figure 46b); as a result, the platelets were probably
deposited just before the reattac hent point in the recirculation zone and therefore
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trapped between the struts. Thus, the inlet just before first strut may be having less
convection of activated platelets and hence, lesser deposition. However, at the outlet, the
recirculation region is small, but the streamlines may be convecting more platelets to that
recirculation region and hence, less deposition just distal to the last strut. Since platelet
deposition has been found to be eater distal to the strut; here also we see slight
increases in platelet deposition in location A compared to location B of Figure 45b.
The platelet deposition peaked distal to the proximal strut and decreased linearly
further downstream, in the region between struts of other stent types. For the over-
expanded NIR stent, the deposition was greater at the center compared to regions close to
the strut (see Figure 46a). Between locations B and C was a small decrease in platelet
deposition and this region may be associated to the reattachment point (see Figure 46b)
Deposition was slightly greater proximal to location C and decreased linearly towards the
proximal strut. Deposition was also slightly greater distal to location B and decreased
linearly towards the distal strut. Increase in deposition proximal to location C or distal to
location B was because of the streamlines that were directed towards the wall and then as
they get more parallel to the wall, the platelets were depleted d the deposition
decreased linearly. Hence, deposition was higher at the center and lower closer to the
struts.
Just as we see variation in platelet deposition axially along the wall, interestingly
we also see variation in platelet deposition circumferentially along the wall. See Figures
42a and 43a. Note that circumferentially along the wall, there are alternative regions of
lower and higher platelet deposition. This was mostly a qualitative observation, based on
quantitative data from other observations stated previously. This must be very common in
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most stent types that have a stent design siilar to that of Bx Velocity stent and Aurora
stent. The repercussions of this observation over long-term restenosis are unknown.
4.4 General Discussion on Platelet Deposition and Its Relationship to Flow
Dynamics
This research study presents dynanic flow experiments with fluorescently labeled
platelets to allow for spatial observation of wall attachment in inter-strut spacings of
stents (three-dimensional - currently marketed in vivo stents, two-dimensional - idealized
versions of three-dimensional stents) to investigate their relationship to flow patterns.
Human blood with fluorescently labeled platelets was circulated through an in vitro
system that produced physiologic pulsatile flow in a flow chamber that featured different
stent designs. Analysis and comparisons are made between 2D stented models and 3D
stents. It is important to keep in mind that 2D stented models were very simple
characterized on a single design parameter, while the 3D stents were more complex
characterized by several different design parameters.
Spatially resolved distribution of platelets was obtained by imaging fluorescently
labeled platelets between the struts. Platelet deposition was higher in areas where flow is
directed towards the wall, and lower in areas where flow is directed away from the wall.
Fully separated regions of recirculation both proximal and distal to the strut were very
small and exhibited very low platelet deposition in 3D stents. This was because of less
mixing of blood from the mainstream flow, thus low amount of activated platelets were
available for deposition. Contradictory to this, it was statistically proved that regions of
recirculation distal to the strut had more platelet deposition in 2D stent models. The flow
detachment and reattachment points could not be easily deciphered using the low spatial
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resolution in 3D stents. But in 2D stents, these deattachment and reattachment points
were very obvious both from the images and the background corrected image intensity
variation plots.
Deposition at the connector region depended on the connector geometry; spirally
recirculating regions had more deposition compared to fully separated regions of
recirculation proximal and distal to the strut. These spirally recirculating regions were
observed only for our 3D stents and not from the 2D idealization models. The spirally
recirculating regions had more complex fluid dynamics than fully separated recirculation
regions proximal or distal to the strut. The use of connectors between stent struts and the
design of the connector is critical towards fluid dynamics and platelet deposition.
Therefore connector design requires careful review.
Circumferentially along the wall in 3D stents, altemative regions of higher and
lower platelet deposition was found. In 2D stent models however, platelet deposition was
evenly distributed all along the direction perpendicular to the flow.
We have seen that the decrease in platelet deposition with axial distance is mostly
a function of how fast the streamlines get parallel to the wall. More number of struts
placed circumferentially like in Aurora stent resulted in depletion of platelets distal to the
proximal strut in the flow direction at a lower rate compared to lesser number of struts
placed circumferentially like in Bx Velocity stent. It is important to note that increasing
strut number circumferentially increases the number of connectors, connecting the
concave and convex ends of the same strut, oriented parallel to the flow direction. This
would imply reduced regions of recirculation around the struts, but increase in the
number ofregions with alternating higher and lower platelet deposition circumferentially.
Hence, one cannot imply that lesser number of struts would result in less platelet
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deposition. Lesser number of struts definitely cause less vascular injury, but platelet
deposition is driven largely by the fluid dynamics within the stented region. Other design
factors like axial and circumferential distance between struts, connector design, and
orientation or strut design (that act in tandem) are important for quantifying overall
platelet deposition.
Semi-expanded stents into the artery wall had more platelet deposition at the
outlet compared to over-expanded stent. Over-expanded stents had large regions of
recirculation primarily at the inlet to the stent, combined with small regions of
recirculation at the outlet. The variation in data was much lower in the over-expanded
NIR stent. The reason for this is that the platelet deposition at the inlet just before over-
expansion was more uniform and higher compared to other stent types. This pattern of
platelet deposition is related to the presence of large recirculation region in the region
around the over-expansion. The use of this data for background correction of images at
the stented region resulted in lesser variation in the results.
What is then the relationship of wall shear stress to platelet deposition? Fig. 49
shows the variation of wall shear stress in the largest strut spacing and the corresponding
platelet deposition variation. Proximal to the distal strut and distal to the proximal strut,
there are regions of recirculation and the wall shear stress is low (see Fig. 49b). However,
platelet deposition is higher distal to the proximal strut and lower proximal to the distal
strut (see Fig. 20a). Between these regions ofrecirculation, the wall shear stress increases
and decreases along the flow direction (see Fig. 49b). But the platelet deposition
continuously decreases linearly between the struts (see Fig. 20a). Therefore, a
relationship between wall shear stress variation and platelet deposition was not seen from
this study. Platelet deposition was hence purely attributed to convective transport of
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activated platelets through the action of instantaneous streamlines. This does not mean
that wall shear stress is not important in the restenosis problem. It definitely is, but could
play a more prominent role in the migration and proliferation of cells. Migration and
proliferation of endothelial cells would have an effect on platelet adhesion in vivo. But
platelet adhesion, activation, and aggregation occurs much faster (few minutes to hours)
than the formation of a healthy endothelial lining (few days) (Haudenschild CC and
Schwartz SM, 1979). Therefore, the results from this research are valid for the acute
stages of stent implantation.
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Figure 49. Mean wall shear stress distribution between struts of largest strut spacing;
locations A to I represent the same locations as in Fig. 20a for comparisons.
The limitations of this study include the simplified 2D stent geometry, the
constitutive model of the blood used in the CFD, and the fact that the phenomena being
modeled here are limited to the acute stages of stent implantation. The limitation in the
135
2D stented study is that the geometry is simple and may not simulate the 3D stented in
vivo behavior. However, experiments were performed under pulsatile flow conditions
with physiologically relevant shear stresses and the analysis allowed for just one single
stent design parameter, L/H. Later on, currently marketed 3D in vivo stents were used for
experimentation and analysis of platelet deposition. Platelet adhesion and aggregation is
the first step in the restenosis process. Therefore measurement of platelet deposition in
the acute stages of stent implantation is valid.
In the CFD study, blood was considered to be incompressible and Newtonian
fluid (Perktold K and Rappitsch G, 1995. Blood may show non-Newtonian behavior at
low shear rates especially in the capillaries. The wall reaction to flow in the stented
region has long been shown to be dependent on wall shear stress (Carlier SG et aL, 2003;
Gijsen JH et aL, 2003). This factor would be important for determining the long-term
effects of intimal hyperplasia or restenosis. But as a result of this research, we have been
able to relate platelet deposition to flow patterns in the acute stages of stent implantation.
Though the causes of long term restenosis using stents are still unknown, this research
may help us to design stents that would avoid excessive platelet aggregation.
Recirculation within stents is unavoidable, however future stents could be designed to
avoid increasing number of recirculation regions so that flow disturbance and platelet
aggregation can be reduced and this may help reduce restenosis rate.
Arteries near branches, curvatures, and stenoses are subjected to complex flow
phenomena. We modeled the flow in a straight section of the artery in this study. This
approach was good as it revealed the mechanics behind platelet deposition to fluid
dynamics. More complex stented geometries could be modeled in future for better
understanding of the platelet adhesion process.
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Our results suggest that convective transport plays an essential role in the
interaction of blood platelets with the endothelial or exposed underlying collagen layer.
An exposed collagen layer naturally attracts platelets, which enhance endothelial cell
migration. This process also affects the development of intimal hyperplasia (IH). The
development of the IH may change the surface contours with the stented region, thus
disturbing the flow pattern; this may in turn result in a different convective transport
pattern of cells. There is limited literature on the 2D and 3D stent studies on platelet
deposition in stented regions; hence, it is possible that some of the findings of 2D and 3D
stents as a result of our research may be applicable to other natural cylindrical stent
models available in the market today. It has been demonstrated that slight changes in
geometry of 3D stents can cause significant changes in flow patterns and wall shear stress
(He Y et aL, 2005).
To analyze the applicability of the 2D stent results in 3D stents, real 3D marketed
stents were used to study platelet deposition and see the similarities and differences in
both studies; they were summarized previously. One of the major limitations of the 3D
stented study was the use of lower magnification lens to capture images. This did not give
us the spatial resolution as high as that in 2D stented models (1 pm). However, many of
the distribution patterns in platelet deposition in 3D could be characterized based on
analysis of streamline information from computational fluid dynamics (CFD) and their
relationship to deposition patterns in 2D (see Fig. 48). Higher spatial resolution and
concentration of specific locations in the 3D stents need to be investigated further
experimentally. This is possible by use of a 2D idealization model of a 3D stent for
experimentation. One could then tr aspose these results to other 3D stented models.
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Computational modeling of 3D stent geometries assumed circumferential and
axial stretching of the vessel wall and the strut height was <8% of the arterial radius,
hence the 3D geometry was planar. In real stented arteries, this assumption is very true.
The artery wall is assumed to be rigid both for computational and experimental purposes.
The effect of wall compliance on flow patterns needs to be investigated further. It has
been shown recently that the temporal wall shear stress gradients are significantly
different in a polygonal stented artery compared to a circular stented artery (LaDisa JF Jr.
et aL, 2005). Also the streamlines obtained from the model for over-expanded NIR stent
and its relationship to platelet deposition patterns at inlet and between first and second
struts proved that the assumption was not insufficient; real-time movies of platelets
between first and second stents of NIR stent showed existence of reversed flow regions
and possible reattachment points. Hence, the streamline information obtained as a result
of modeling the 3D geometry as planar is accurate in the context of this study.
A question that arises as a result of this research - what would be an optimal stent
design? A simple answer would be something that has maximum number of struts
oriented circumferentially to maintain a circular geometry after implantation, minimum
of struts along the axial flow direction, simple geometry for the connector (mainly
oriented along flow direction), and to have connectors only where necessary.
4.5 Conclusion and Future work
We have identified distinct flow regions within struts, such as recirculation,
reattachment, and separation, and correlated these flow regions with localized platelet
deposition in a highly resolved scale. Previous measurements of platelet deposition in an
expanded tube (Karino T and Goldsmith HL, 1979) showed a peak in platelet adhesion in
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the vortex in which the platelet density was appreciably greater than that downstream of
the reattachment point where fully developed laminar flow was established. They
attributed platelet deposition to convective transport of platelets through the
instantaneous streamlines. Distal to the tubular expansion, ie. just downstream of the
reattachment point, the platelet attachment was lower than in the region of recirculation
because of the decreased velocity of platelets striking the wall. The geometry of the
tubular expansion was different from that of the stented region considered here, and the
shear stresses in the tubular expansion geometry were much higher. However, at the
reattachment point, platelet adhesion was a minimum. This may be a result of the wall
reaction rate and wall shear stress. If the wall reaction rate is linearly dependent on the
wall shear stress, the platelet flux is maximum upstream of the stagnation point (David T
et aL, 2001). Aneurysm and arterial stenosis flow models showed greater platelet
deposition in the regions of recirculation at the distal end for low Reynolds numbers
(Bluestein D et aL, 1996, 1997). Results obtained in the regions of recirculation,
separation and reattachment in our research (Chapter 3 and 4: sections 4.1, 4.2, 4.3, 4.)
confirm these previous findings.
The use of streamlines for quantification of platelets in each location between the
stent struts is a valuable tool. Based on inferences made from both 2D and 3D stent
studies so far, it may be possible to guess the platelet deposition in a region not analyzed
experimentally. For example, in NIR stent, images of platelet deposition at locations A
(proxiral to connector in Figure 50a) and B (distal to connector) were not taken; what
would be the degree of platelet deposition within these locations? Assume that we are
looking at deposition far away from the recirculation region at the inlet. The
instantaneous streamlines from CFD show that there is a region of separation away from
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the wall proximal to the connector while no flow separation occurs distal to the connector
(see Figures 5Gb, 50c). Apart from streamlines that carry activated platelets from location
A to location B, Figure 50a shows that strearines from the center of the struts also carry
activated platelets down to location B. Based on the above, platelet deposition is expected
to be lower in location A and higher in location B. For example, in Bx Velocity stent,
there was more platelet deposition at the inlet near the connector of the concave and
convex ends of the first strut at the inlet (see Figure 38a); this was similar to the 3D
stented geometry (see Fig. 23c) where a separation parameter was used to characterize
regions of the wall susceptible to platelet deposition; separation parameter existed all
along the inclined portions of the connector. However, in Aurora stent, there was no
platelet deposition near the connector of the concave and convex ends of the first strut.
This difference in platelet deposition is related to the degree of stent strut orientation in
the flow field; the connectors connecting the concave and convex end of the strut in
Aurora stent were oriented in the direction of flow and hence no deposition was seen.
This observation is similar to the 3D stented geometry (see Fig. 28c) where separation
parameter existed at the apex and base oft the struts. 3D CFD evaluations of other stented
geometries were helpful to analyze current experimental results also. The above example
showed that the more inclined the strut to the flow direction, the greater the platelet
deposition along the length of the connector. Thus, CFD analysis can be very useful in
relating geometrical changes to platelet deposition. Further experimental investigations
should be performed under higher spatial resolutions to confirm platelet deposition
patterns in and around complex recirculation regions and also at the converging and
diverging junctions of the struts.
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Figure 50. (a) Streamlines (at maximum flow rate) above the proximal portion of the
connector have the capability to travel distal to the connector for NIR stent; (b)
streamlines proximal to the connector undergo flow separation; (c) streamlines distal to
the connector do not undergo flow separation. One could then expect that the platelet
deposition at region E would be greater than at region D.
Quantification of relative rates of platelet deposition requires more complex
modeling of particle-wall interactions in non-parallel flow domains (Longest PW and
Kleinstreuer C, 2003). Many arteries may be subjected to reversed flows; the platelet
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deposition could vary spatially due to these reversed flows. In 2D stents, we think that
reversed flow may cause platelet deposition to be evenly distributed within the stent
struts. In 3D stents, the deposition pattern may be more complex. Additional
computations performed based on generic parametric 3D geometries and their
comparison showed that regions of partial recirculation or partial reattachment were
greater in reversed flow compared to forward flow (see Fig. 32). Further investigations of
fluorescent platelet tracking could be done to reveal the exact mechanisms involved in
platelet deposition under reversed flow conditions.
This study has demonstrated the effects of geometric configuration of stents on
the flow characteristics and platelet deposition under physiological shear and pulsatile
flow conditions in the acute stages of implantation. There are likely other portions of the
restenosis process that can be modulated by changes in stent geometry. Such information
can be used to improve stent design. For example, stent designs like the compliance
matching stent have been shown to restrict local restenosis in vivo (Rolland PH et aL,
2004). One of the main aims of this study was to show that fluid dynamics plays an
important role in platelet de sition in stented regions. Further experirental
investigations (both in vitro and in vivo) should be performed to correlate platelet
deposition with other factors involved in restenosis - (1) many of the processes of
thrombus and neoint al formation were not consider as p of this research; (2) stent-
to-wall interactions involved in arterial remodeling were neglected and could form the
basis for another research study; (3) changes in the arterial geometry due to existence of
akeady formed plaque were omitted; (4) circumferential mechanical stresses exerted on
the wall due to stent design were not considered; and (5) existence of tissue prolapse and
arterial compliance on the arterial wall strain and flow mechanics is unknown. Before we
142
he answers to these processes mentioned above, it would not be appropriate to say if
e have an optimal stent design.
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Appendix B - Stock Solution Preparation
Heparin
Ingredients:
z 50 mg of heparin sodium
* 166.5 ml of O.9% NaCl
Mix together and pass though a 22 m membrane filter. Solution should be
stored at 4*C. Using 5 of Heparin solution corresponds to 270 units of
Heparin.
Mepacrin~e
In edients:
* 47 mg of mepacrine
* 10 ml of distilled water
Mix together and store stock at 4'C. Using this, we prepare a 10 m mepearine
stock.
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Appendix C - Procedure of Blood Collection
Syringe Preparation for Blood Withdrawal
1. Take three 60 ml syringes.
2. Extract 5 ml of Heparin solution (270 units) into each syringe.
3. Give all three syringes to the phlebotomist for blood withdrawal.
4. Collect 50 of blood into the syringes therefore filling to a total of 55mi
each.
5. Place s inges on rocker or maintain at 37 degree celsius until use.
Only 2 syringes (total of 100ml blood) were required for 3D experiments.
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T Appendix D - IRB Proposal
MAm~viipublic researcI un 7ersi
EFFECT OF BLOOD FLOW PATTERNS ON PLATELET DEPOSITION
IN 2D AND 3D STENTED ARTERIES
- AN EXPERIMENTAL AND COMPUTATIONAL APPROACH
RESEARCH OBJECTIVES:
Introduction Percutaneous transluminal coronary angioplasty
was introduced to treat occlusive vascular disease, but was associated with 40% or more
restenosis rate. Now-a-days, vascular stents form an effective treatment for occlusive
vascular disease. The use of stents after balloon angioplasty maintains the lumen
diameter and therefore prevents vessel recoil. However 20% to 30% of patients receiving
endovascular stents develop significant restenosis. Restenosis is related to patient-, and
procedure-specific factors. Patient-specific factors such as disease-specific or gene-
specific cannot be influenced by any means; procedure-specific factors that influence
restenosis include implantation technique, complexity of the artery, and stent design and
material make-up. Many researchers have sought to address these problems by
modulating stent surface characteristics, by treating patients with a variety of antiplatelet
therapy, by coating stents with drugs such as sirolimus, paclitaxel, or actinomycin D, and
by manufacturing stents of different designs (currently, 55 kinds of stents are available in
the market). However, the success of each of these procedures used to reduce restenosis
rate has been limited. The success has been limited by an increase in cases of severe
160
bleeding and hemorrhaging with pharmacological treatments; drug coated stents reduce
smooth muscle cell proliferation, but have shown good short-term success only; different
stent designs have still not helped in reducing the restenosis rate drastically.
Both in vitro and in vivo studies have revealed that stent design influences
thrombus accumulation between struts and restenosis. The presence of a t ombogenic
metallic surface, along with the denudation of endothelium creates favorable conditions
for platelet adhesion to the vessel wall. New techniques in coating stents with non-
thrombogenic materials and evidence that variations in geometric configuration of stents
lead to reduced endothelial injury have sought to address the issue. Major determinants of
the stent profile include shape and height of strut, number of intersections, and metal-to-
artery ratio. In fact, stents designed with fewer strut-strut intersections were reported to
lead to significantly less neointimal hyperplasia. Reducing strut-strut intersections by
29% while keeping diameter, mass, and surface area constant m denuded rabbit iliac
arteries reduced vascular injury by 42%, thrombosis by 69%, and ncointimal hyperplasia
by 38%. The use of a thin-strutted stent was associated with a 43% reduction in the
restenosis rate at six months compared to a thick-strutted stent. Clinical studies have
shown stent design to be the second greatest risk factor for determining restenosis, second
only to vessel size. Mechanical factors influenced by stent design include stress
concentration on the artery wall and the disruption of blood flow imposed by stents.
The protrusion of individual stent struts into the flow field affects the flow
adjacent to the artery wall, creating areas of flow stagnation near the struts. Low mean
wall shear stresses associated with these areas of stagnant flow, along with high particle
residence times, and non-laminar flow, have all been shown to create favorable
conditions for intimal thickening. The first step to intimal thickening may be related to
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the rate and extent of platelet deposition near stented regions. The study of platelet
deposition in an expanded tube showed a peak in platelet adhesion in the vortex in which
the number density was appreciably greater than that downstream of the reattachment
point where fully developed laminar flow was established. At the reattachment point,
platelet adhesion was a minimum. This may be a result of the wall reaction rate and wall
shear stress. If the wall reaction rate is line ly dependent on the wall shear stress, the
platelet flux is maximum downstream of the stagnation point. Further, as stated
previously, the simple inclusion of a gap between individual stent struts has been shown
to produce significantly less neointimal formation than stents with no gaps between stent
struts. Numerous computational fluid dynamics simulations have shown that the creation
of areas of flow recirculation (where the wall shear stress is usually low) and
reattachment (where the wall shear stress is usually high) between individual stent struts
throughout the cardiac cycle are dependent on stent strut spacing. The study of the
Wallstent wire mesh stent revealed that a strut spacing less than six wire diameters lead
to constant flow separation zones between the struts where as a strut spacing greater than
six vessel diameters lead to flow reattachment between the struts. Thus blood flow
patterns strongly depend on stent strut spacing, thereby affect platelet deposition between
struts.
The influence of stent design on solid mechanics conditions inside the stented
artery may also play an important role in stent failure and restenosis. A compliance
matching stent has been designed to reduce the abrupt changes in mechanical propeties
(compliance) at the ends of the stent and the arterial wall that create zones of high stress
concentration. The higher stress in the stented region may cause the endothelial layer of
the arterial wall to denude and thus the artery wall must adapt to accommodate these new
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stresses by the generation of additional tissue, which may eventually lead to restenosis.
Researchers have shown that the arterial injury produced by stents creates a strong
stimulus for smooth muscle cell proliferation and neointimal hypelasia. Such injury to
the artery attracts platelets for repair. Lowest platelet deposition has been shown to occur
within the smallest strut spacing. However, no research is available regading the effects
of blood flow patterns on localized platelet deposition within the stented region and their
relationship to wall shear stress variations either in 2D or 3D.
This study will focus on the dynamics of blood flow and its effects on the platelet
deposition near stented region, of particular interest within different stent strut spacings,
in the acute stages of stent implantation. Two dimensional stent models will be selected
to simulate cases of constant recirculation of blood flow, constant reattachment of blood
flow, and intermittent reattac ent of blood flow between individual stent struts. The
platelet deposition will be quantified at different times between two individual stent struts
and the deposition pattern will be compared to computational wall shear stress patterns
for each of the stent models. The limitation in the 2D study is that the geometry is simple
and will not simulate the in-vivo behavior of the artery wall to platelet deposition due to
the flow dynamics and the geometry. Hence platelet adhesion studies within three
dimensional stent models will be performed to correlate their relationship to localized
changes in wall shear stress pattern. However, the 2D study will provide insight on
platelet deposition at specific regions of disturbed flow in the stented section; this
information will be useful to depict platelet deposition patterns in the 3D study but there
may be other concerns that will be observed only on 3D experimentation.
* The theoretical goal of this research is to study the effect of blood flow dynamics and
time course on platelet adhesion in stented arteries and the relationship to the
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computational wall shear stress pattern. The empirical goal of this research is to be
able to address the role of some mechanical factors in restenosis and thereby
minimize it with a better stent design.
* The involvement of the research subject(s) helps us to carry out the research project
as needed d be able to prove the theoretical and empirical goals of the researc
project. By minimizing the effects of restenosis, patients (who get stents) will feel and
perform better on a daily basis. This invokes a sense of satisfaction and achievement
for all subjects who involve in this research.
SUBJECT RECRUITMENT:
Information: Recruitment refers to the contact and the communication that takes place
between the investigator and a potential particip nt. Recruitment occurs prior to the
introduction of the consent process. Recruitment methods include but are not limited to
verbal exchanges and advertisement. Recruitment processes should avoid the appearance
of coercion or undue influence.
* Subjects to be included in this research are normal volunteers (i.e. people with no
physiological diseases or disorders of any kind, non-smoking, non-alcoholic, and
taing no medications that alter blood function); they are estimated to be 30 in total
number.
* The source of potential subjects will be mostly students who work or study at the FlU
engineering center and/or their relatives.
* Potential subjects will be approached personally; they will be contacted through
phone or through their department at FliU engineering center. Advertisements will
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also be put up wherever needed so that subjects could get in touch with the principal
investigator or the faculty advisor directly. Prior to the study, the main research goals
will be explained to the subject and a promise to keep their identity confidential will
be made prior to obtaining consent. There will be no direct risk or benefit to the
subjects involved.
* All normal volunteers can be included in the study. We reiterate that volunteers
should not smoke and should not have consumed alcohol over a period of 24 hours.
Volunteers should not have consume drugs like aspirin over a period of 48 hours.
METHOD AND PROCEDURES:
* There are no direct risks involved with the study protocol. Minimal risks if any, are
the same with this study protocol as it would be with the blood donation procedure.
150nl of blood will be drawn from the subject through venipuncture. A licensed
phlebotomist, Bhavani Jayachandran (Undergraduate advisor, Biomedical
Engineering, FIU) will be present to withdraw blood from the subject, thus
minimizing all risks to the subject. All needles, bottles used are disposable and will be
used only one time. Hence, the risks to the subject are minimal. There may be slight
bruising at the point of the venipuncture, which will be covered using cotton and
bandaid pads; these bruises usually disappear in a matter of hours on the same day of
blood donation.
* Research will be conducted only at the Cardiovascular Engineering Center,
Biomedical Engineering, FlU, Miami.
* Expected start date is 2 0 th November, 2004. Expected end date is 26 November,
2005.
165
No tests or examinations are done on the subject. All normal volunteers who can
donate blood are eligible; their blood will not undergo any kind of processing before
the experiment.
There are no alternative procedures or treatments that the subject may be able to
consider.
The procedure is very simple and standard to that of any blood donation procedures
and hence no particular treatment is needed since the amount of blood to be
withdrawn is very minimal.
The heparinized blood collected by the phlebotomist will be used by the P1 for the
experiments. The hep inized blood will be stained by mepacrine (a nucleic acid
stain) to stain the platelets and the leucocytes; these stained cells could then be
observed under the fluorescent microscope (Nikon TS100 with mercury arc lamp) in
dark as the blood flows in the stented region with a pulsatile pump. The reservoir
where the blood collects will be maintained at 37 degree celsius. No testing will be
performed with the blood.
Data to be collected will consist of image files showing fluorescent platelets inside
the stented region. Data will be collected over a 30 minute time span, using image
capture software called streampix as of images. Each image captured at one time
point will consist of several frames. Selected number of frames of each image will be
averaged using image processing software called imagepro to reduce error from light
intensity changes due to AC lamp fluctuations. The averaged frame will be then used
for light intensity background correction (using a custom program written in matlab).
The image file at the no flow disturbance region will be used for background
correction of the actual image file at the stented region. Variations in platelet
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deposition between struts will be then compared to wall shear stress variations from
computational fluid dynamics (CFD). Data will be analyzed in Excel or SPSS
software.
* No cost or compensation is involved as a result of participation in this research. In
order to help the subject regain strength after the donation, a pack of cookies and
juice is provided for free.
BENEFITS:
- There are no direct benefits to the subject, but the research itself provides anticipated
benefits to the society in general. If this research helps in providing information on
designing a stent better than the current designs, it has benefited the patient by
reducing the restenosis rate. As part of this research, the subject may be able to gain
knowledge of the specific discipline.
* The level of major risk in relation to anticipated benefits is null. As stated before, the
risks as part of this study if any are the same as that for any blood donation
procedure; these risks are however minimal such as discomfort of the needle or small
bruising.
RISKS TO SUBJECTS:
- There are no long-range risks associated with the procedure. Some immediate risks
include discomfort due to the needle and slight bruising. Discomfort of the needle
usually disappears if one maintains their calm and takes a deep breath. Discomfort
may also disappear if the position of the needle is changed slightly within the vein
(done by the phlebotomist). Slight bruising is characteristics due to the needle prick.
167
Cotton and bandaid will be used to cover the wound to prevent infection and in a
matter of hours, the bruising will disappear. The risk of infection is very minimal
because only disposable needles will be used for blood withdrawal. The
confidentiality of the subject will be maintained and hence, no legal risk is involved.
No medical or psychological care is available as part of this research as the operating
procedure is simple and does not require one. Psychologically, care will be provided
by the principal investigator and the phlebotomist at the time of blood withdrawal to
ke the subject at ease. To augment the physical condition of the subject after the
blood withdrawal procedure, some cookies and juice will be provided.
There is no scientific necessity of the experimental aspects that lead to these risks. No
legal risks are involved as the confidentiality of the subject will be maintained.
There are no known risks to the subject. The risk level is very minimal in this study as
mentioned above since only 150m1 of blood is withdrawn and are not great than if
the same procedure is faced in normal blood donation scenario (where more than
500m1 of blood is withdrawn usually).
NFORMED CONSENT:
Informed consent forhas been prepared with the idea that the person giving consent
for blood withdrawal for this research is able to understand the relevant information
about the research and understands clearly the benefits and risks if any.
Informed consent will be obtained before blood withdrawal and after giving a brief
explanation of the research project by the principal investigator, free of coercion or
any undue influence.
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* The subject will be welcome to clarify or ask rther questions about the informed
consent to the principal investigator or the faculty advisor, before giving consent.
* Adult consent only will be used.
* A copy of the written informed consent form is attached to the application.
CONFIDENTIALITY OF DATA:
* The consent forms and records will be maintained in a separate location (file cabinet)
that will always remain locked; the keys will be accessible only to the P1; the PI will
also have information on all people from the department who have access to the keys.
The consent forms will be maintained on file for at least 3 years from the start of the
research d disposed (by shredding) later on. This is how subject data will be
safeguarded.
* Other than the consent form, there is no place elsewhere in the research where the
subject name or other details regarding the subject will be used (or appears).
* Gender is not a criteria for this research; hence this information also does not appear
and thus remains confidential.
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NFORMVED CONSENT
EFFECT OF BLOOD FLOW PATTERNS ON PLATELET DEPOSITION IN
STENTED ARTERIES
I freely and voluntarily consent to be a participant in the research project referenced
above to be conducted at Florida International University during the 2004-2005 academic
year, with Nandini Duraiswamy as Principal Investigator. I have been told that the blood
collection procedure will last approximately 10 minutes.
I understand that the purpose of the research is to gain further understanding of the
role of blood flow patterns in platelet deposition in stents (devices used to treat
cardiovascular diseases).
I understand that the procedures will be as follows: 150 milliliters of blood will be
collected by venipuncture from the forearm into three 50 cc syringes containing heparin
as an anticoagulant. This blood sample will then be used in blood flow experiments
designed to measure platelet deposition.
I understand that there are no known benefits involved in my participation. I
understand the venipuncture presents a minimal risk of infection, discomfort and possible
bruising. I have been told that individual data regarding the blood sample will be kept
confidentiaL. The data will be coded and the key to the code will be kept in a locked
cabinet with access only available to the PI.
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I understand that I may withdraw my consent and discontinue participation in this
research project at any time with no negative consequences. I have been given the right
to ask questions concering the procedure, and any questions have been answered to my
satisfaction.
I understand that if I desire further information about this research I should contact
Nandini Duraiswamy (Principal Investigator of this research) or Dr. Richard
Schoephoerster (Faculty Advisor) at (305) 348-6950. I understand that if I have
questions regarding the rights of research subjects, I should contact Dr. Jonathan G
Tubman (Chair of the University Research Committee) at (305) 348-5290. I have been
offered a copy of this informed consent form.
I have read d understand the above.
Participant's signature Date
Print name
I have explained and defined in detail the rese rch procedure in which the participant
has agreed to participate, and have offered him/her a copy of this informed consent form.
Principal Investigator's signature Date
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